Atopic dermatitis, strict definition with reimbursement

ATOPIC_STRICT_REIMB

atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 134\|395\|317 1 out of 7 registries used, show all original rules.	3622
4. Check minimum number of events None	3622
5. Include endpoints ATOPIC_STRICT	16855
6. Filter based on genotype QC (FinnGen only)	16317

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	ATOPIC_STRICT_REIMB
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	ATOPIC_STRICT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	134\|395\|317
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atopic dermatitis, strict definition with reimbursement based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16317	11425	4892
Unadjusted period prevalence (%)	3.51	4.05	2.24
Median age at first event (years)	24.84	25.73	22.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16678: Matched controls
161001

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D11AH05

ATC

dupilumab; topical

518.1

315.0

317

L40.0

ICD-10 Finland

Psoriasis vulgaris

4.1

308.8

881

2136

D07AA02

ATC

hydrocortisone; topical

9.7

307.7

7075

11413

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.4

307.7

3811

17690

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

307.7

2444

R06AX13

ATC

loratadine; oral

3.1

307.7

4110

15466

D11AX14

ATC

[U] tacrolimus

+∞

307.7

853

D11AX15

ATC

[U] pimecrolimus

+∞

307.7

404

D07AB01

ATC

clobetasone; topical

6.7

307.7

944

1423

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

12.0

307.7

650

544

L30.0

ICD-10 Finland

Nummular dermatitis

5.8

307.7

661

1131

D07AD01

ATC

clobetasol; topical

4.3

307.7

3773

10356

H02AB06

ATC

prednisolone; systemic

2.7

307.7

8606

45288

R06AX27

ATC

desloratadine; oral

3.0

307.7

7625

35125

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.8

307.7

2788

10627

L27.2

ICD-10 Finland

Dermatitis due to ingested food

210.1

307.7

867

D11AH02

ATC

pimecrolimus; topical

+∞

307.7

741

J01DA01

ATC

[U] cefalexin

1.9

307.7

10242

73414

S01GX02

ATC

levocabastine; ophthalmic

3.2

307.7

1483

4830

R06AE07

ATC

cetirizine; oral

3.8

307.7

10783

52411

E000002, ,

ATC

10.1

307.7

5850

8184

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

256.5

307.7

490

L28.1

ICD-10 Finland

Prurigo nodularis

64.3

307.7

191

134

Kela drug reimbursment

General erythroderma

+∞

307.7

531

D07BA04

ATC

hydrocortisone and antiseptics; topical

8.3

307.7

4976

7839

D07BC01

ATC

betamethasone and antiseptics; topical

5.7

307.7

3235

6527

E0000UV, ,

ATC

11.6

307.7

13263

40439

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.9

307.7

3209

7527

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.9

307.7

1615

3472

D07AC01

ATC

betamethasone; topical

6.0

307.7

9418

28510

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

99.3

307.7

509

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

307.7

1508

L30.3

ICD-10 Finland

Infective dermatitis

15.0

307.7

1045

714

H02AB07

ATC

prednisone; oral

2.8

307.7

2310

8810

E000007, ,

ATC

9.6

307.7

2683

3163

D02AE01

ATC

carbamide; topical

7.9

307.7

2359

3289

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

307.7

2998

D07AB08

ATC

desonide; topical

12.3

307.7

5351

5938

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

307.7

3703

15581

XQ802

NOMESCO Finland

Epicutan test

62.3

307.7

2647

486

D07AC13

ATC

mometasone; topical

6.9

307.7

8725

22089

49300

ICD-8 Finland

Asthma, bronchiale

6.7

307.7

567

843

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.8

307.7

1052

1837

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

20.3

307.7

290

140

D07AB02

ATC

hydrocortisone butyrate; topical

6.1

307.7

8721

24449

D07AC14

ATC

methylprednisolone aceponate; topical

6.7

307.7

1452

2258

C01CA24

ATC

epinephrine; parenteral

4.4

307.7

2162

5247

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

4.3

307.7

2473

6335

R03AC02

ATC

salbutamol; inhalant

2.3

307.7

10413

67887

TQW80

NOMESCO Finland

Local dermatologic skincare

13.0

307.7

803

626

XQ800

NOMESCO Finland

Prick test

9.5

307.7

3749

4754

D07XC01

ATC

betamethasone; topical

3.6

307.7

2307

6848

H02AB04

ATC

methylprednisolone; systemic

2.6

307.7

2453

10136

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

307.7

2458

L20

ICD-10 Finland

Atopic dermatitis

+∞

307.7

2360

D07XB05

ATC

dexamethasone; topical

6.7

307.7

752

1125

E000004, ,

ATC

10.9

307.7

862

801

S87

ICPC

Dermatitis/atopic eczema

12.2

307.7

1300

1108

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

307.7

518

L30.9

ICD-10 Finland

Dermatitis, unspecified

5.0

307.7

4962

12537

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

52.8

307.7

269

395

Kela drug reimbursment

Dupilumab

+∞

307.7

325

S01GX01

ATC

cromoglicic acid; ophthalmic

3.4

307.7

5756

21592

J45

ICD-10 Finland

Asthma

2.8

307.7

2222

8514

D05BB02

ATC

acitretin; oral

8.6

307.7

560

651

R06AX22

ATC

ebastine; oral

2.9

307.7

4119

16142

D11AH01

ATC

tacrolimus; topical

912.4

307.7

1774

N05BB01

ATC

hydroxyzine; systemic

7.0

307.7

2465

3874

D09AB01

ATC

zinc bandage without supplements; topical

19.8

307.7

681

346

R03BA05

ATC

fluticasone; inhalant

2.4

307.7

3825

18015

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

10.0

307.7

4215

5251

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

13477

D02AX

ATC

Other emollients and protectives

12.8

307.7

1721

1432

E000006, ,

ATC

7.8

307.7

2479

3515

R03AC03

ATC

terbutaline; inhalant

2.4

307.7

2674

11851

R06AE09

ATC

levocetirizine; oral

3.8

307.7

4382

13949

D07CC01

ATC

betamethasone and antibiotics; topical

4.5

307.7

3359

8577

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

6.9

307.7

4753

8779

R03BA02

ATC

budesonide; inhalant

2.5

307.7

3672

16274

E000003, ,

ATC

12.5

307.7

2215

1943

E000001, ,

ATC

9.0

307.7

8431

16469

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

28.1

307.7

707

253

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

90.5

307.7

349

R03DC03

ATC

montelukast; oral

2.6

307.7

3709

15958

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

307.7

4327

15892

J30.3

ICD-10 Finland

Other allergic rhinitis

3.7

304.7

1031

2822

XQ848

NOMESCO Finland

Dermatological photography

5.9

298.7

551

922

T78.4

ICD-10 Finland

Allergy, unspecified

3.3

296.4

1208

3727

J01DB01

ATC

cefalexin; oral

2.2

282.9

13993

113912

S01GX08

ATC

ketotifen; ophthalmic

3.3

278.2

1140

3526

Z51.6

ICD-10 Finland

Desensitization to allergens

5.7

271.6

517

891

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

89.5

271.5

147

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

9.3

265.2

325

342

R96

ICPC

Asthma

2.6

262.3

1716

6843

S01BA01

ATC

dexamethasone; ophthalmic

4.3

259.1

699

1622

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

23.6

257.4

189

R06AX26

ATC

fexofenadine; oral

2.7

251.3

1514

5792

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

18.8

247.5

200

104

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

240.6

2202

10187

R06AX18

ATC

acrivastine; oral

4.5

239.5

601

1317

D06AX01

ATC

fusidic acid; topical

2.4

239.0

1867

8069

R03BA01

ATC

beclometasone; inhalant

2.2

228.2

2268

10833

D07CB01

ATC

triamcinolone and antibiotics; topical

5.8

226.6

429

735

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.8

224.1

714

1869

S01AD03

ATC

aciclovir; ophthalmic

3.9

219.4

680

1746

R01AD09

ATC

mometasone; nasal

1.7

218.8

7989

57158

L30.8

ICD-10 Finland

Other specified dermatitis

5.0

218.7

485

959

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

88.2

217.5

118

R01AD08

ATC

fluticasone; nasal

1.8

217.1

4981

31427

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

200.3

3574

20853

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

6.4

191.7

325

499

Z3231

NOMESCO Finland

Registered nurse

1.8

190.2

4101

25250

L04AA01

ATC

[U] ciclosporin

6.4

189.3

321

493

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

20.4

189.0

147

J01DA09

ATC

[U] cefadroxil

1.7

185.8

4331

27226

L04AX03

ATC

methotrexate; systemic

2.3

185.7

1568

6973

L28.0

ICD-10 Finland

Lichen simplex chronicus

15.9

185.4

162

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

25.6

181.0

129

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

9.7

177.2

210

211

L26

ICD-10 Finland

Exfoliative dermatitis

1770.0

175.9

173

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

9.5

174.8

210

215

J01FF01

ATC

clindamycin; systemic

1.7

172.0

3935

24522

A92

ICPC

Allergy/allergic reaction NOS

3.0

172.0

807

2689

D05AX52

ATC

calcipotriol, combinations; topical

2.9

169.3

841

2892

S29

ICPC

Skin symptom/complaint other

1.8

169.1

2787

15772

D07AC03

ATC

desoximetasone; topical

5.7

167.3

319

550

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

58.3

166.3

D05AX02

ATC

calcipotriol; topical

3.6

164.9

559

1524

J45.8

ICD-10 Finland

Mixed asthma

3.5

161.7

585

1665

R03AC12

ATC

salmeterol; inhalant

3.2

159.2

644

1966

WQ007, ,

NOMESCO Finland

71.2

157.4

S01GX09

ATC

olopatadine; ophthalmic

3.2

156.9

636

1944

R01AC01

ATC

cromoglicic acid; nasal

2.7

156.8

879

3222

R01AD58

ATC

fluticasone, combinations; nasal

1.6

153.6

4688

31319

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

153.4

751

2560

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

150.8

3783

24036

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

150.6

1165

4974

L50.3

ICD-10 Finland

Dermatographic urticaria

4.3

150.5

395

895

S21

ICPC

Skin texture symptom/complaint

1.9

150.4

2030

10735

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

148.0

5194

35803

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

9.1

147.2

183

196

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

3.8

144.7

455

1178

L04AD01

ATC

ciclosporin; systemic

4.2

142.4

388

905

J05AB01

ATC

aciclovir; systemic

1.7

141.1

3257

20196

J46

ICD-10 Finland

Status asthmaticus

3.4

140.5

517

1487

R01AD05

ATC

budesonide; nasal

2.2

140.4

1221

5474

A46

ICD-10 Finland

Erysipelas

2.0

135.4

1538

7642

WQ000

NOMESCO Finland

Hyposensibilisation

6.0

131.7

236

383

R01AD01

ATC

beclometasone; nasal

1.8

131.4

2301

13175

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

8.8

131.2

168

187

R01AD12

ATC

fluticasone furoate; nasal

1.5

128.1

5713

41204

R03DA04

ATC

theophylline; systemic, rectal

3.0

127.2

588

1939

R03AC13

ATC

formoterol; inhalant

2.7

126.0

712

2616

S01GX05

ATC

lodoxamide; ophthalmic

4.8

123.9

283

573

L50.9

ICD-10 Finland

Urticaria, unspecified

2.6

123.4

769

2966

B00.10

ICD-10 Finland

Herpes simplex facialis

5.3

123.4

252

463

S01GX04

ATC

nedocromil; ophthalmic

4.0

122.5

357

875

R06AX12

ATC

terfenadine; oral

2.5

122.5

803

3173

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.5

120.4

820

3298

D05AX03

ATC

calcitriol; topical

5.5

120.4

237

421

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.6

119.5

407

1112

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

20.8

119.1

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.1

117.5

511

1627

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

9.0

117.4

147

159

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

6.9

114.6

179

252

L29.9

ICD-10 Finland

Pruritus, unspecified

3.7

113.3

374

1001

L50.0

ICD-10 Finland

Allergic urticaria

3.0

112.5

530

1766

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.7

111.8

267

561

H01.0

ICD-10 Finland

Blepharitis

2.1

110.8

1177

5692

R06.0

ICD-10 Finland

Dyspnoea

1.6

110.0

3172

20640

R03BA08

ATC

ciclesonide; inhalant

2.0

106.9

1313

6686

R03BB04

ATC

tiotropium bromide; inhalant

2.2

106.5

954

4316

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

106.2

560

1984

WIX00

NOMESCO Finland

Allergy cleanup guidance

26.0

105.7

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

105.5

1581

8596

R03BC01

ATC

cromoglicic acid; inhalant

3.6

105.4

361

990

XQ830

NOMESCO Finland

Exposure to foodstuff

26.6

105.1

L08.0

ICD-10 Finland

Pyoderma

5.2

104.7

217

404

E0001A1, ,

ATC

2.9

102.0

509

1750

J05AB11

ATC

valaciclovir; oral

1.7

101.7

2006

11821

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

101.6

5105

37286

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

99.4

9577

78536

J01FA10

ATC

azithromycin; systemic

1.4

99.4

10013

82759

J30.19

ICD-10 Finland

Pollen allergy UNS

2.2

99.3

913

4173

R02

ICPC

Shortness of breath/dyspnoea

1.8

96.6

1677

9522

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

94.9

666

2713

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

13.1

94.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

94.4

2575

16467

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

94.2

752

3242

XQ817, ,

NOMESCO Finland

34.8

94.0

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

92.9

3640

25219

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

92.4

2000

12065

L40.8

ICD-10 Finland

Other psoriasis

6.1

90.9

159

252

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.7

90.5

170

289

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

88.8

730

3185

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

87.9

3833

27084

R06AX11

ATC

astemizole; oral

2.5

87.6

584

2322

68408

ICD-8 Finland

Impetigo, Alia definita

17.9

87.3

E000005, ,

ATC

22.1

85.0

J01FA06

ATC

roxithromycin; oral

1.4

84.4

5239

39458

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.5

84.1

293

813

50708

ICD-8 Finland

Hay fever, Alia definita

7.8

83.8

117

145

XQ899

NOMESCO Finland

Other assessment of skin

9.5

83.5

100

102

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

83.3

WQ021, ,

NOMESCO Finland

31.3

82.2

WQ066, ,

NOMESCO Finland

44.0

81.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

81.4

3178

21918

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

5.9

80.9

147

242

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.6

80.5

195

415

L01

ICD-10 Finland

Impetigo

3.1

80.5

344

1084

S88

ICPC

Dermatitis contact/allergic

3.0

78.3

359

1178

S76

ICPC

Skin infection other

2.2

78.1

666

2949

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

77.5

4200

30785

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

76.7

656

2907

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.9

76.6

171

340

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.9

76.5

1120

6022

J01FA01

ATC

erythromycin; systemic

1.5

75.3

2423

16017

J02AC02

ATC

itraconazole; systemic

1.6

74.5

2242

14599

505

Kela drug reimbursment

Allergy to cow's milk in infants

13.6

73.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

72.9

1811

11270

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

72.2

5711

44473

68600

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

31.0

71.5

R06AE08, ,

ATC

4.3

71.3

185

416

WQ020, ,

NOMESCO Finland

42.6

71.2

R01AD11

ATC

triamcinolone; nasal

1.8

70.2

1201

6764

D07AB09

ATC

triamcinolone; topical

6.4

70.1

118

180

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

9.2

69.9

S01GX06

ATC

emedastine; ophthalmic

3.7

69.0

226

602

S01BA04

ATC

prednisolone; ophthalmic

3.3

68.9

266

788

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

68.9

D06BX01

ATC

metronidazole; topical

1.7

68.9

1396

8240

WZC30

NOMESCO Finland

Teaching

1.6

68.5

1755

10994

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

68.0

1459

8740

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

67.9

1312

7644

M79.6

ICD-10 Finland

Pain in limb

1.3

67.4

5758

45248

R01AC02

ATC

levocabastine; nasal

2.4

67.1

490

2030

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.8

66.9

1170

6628

S02

ICPC

Pruritus

2.2

66.5

574

2552

D07XA01

ATC

hydrocortisone; topical

8.4

66.3

100

M25.5

ICD-10 Finland

Pain in joint

1.4

65.7

4564

34699

R03CC02

ATC

salbutamol; systemic

1.6

65.2

1576

9726

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.2

64.5

256

772

D06BB03

ATC

aciclovir; topical

2.1

64.4

645

3041

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

4.7

64.0

149

307

L17

ICPC

Foot/toe symptom/complaint

1.4

64.0

3761

27798

L50.8

ICD-10 Finland

Other urticaria

2.9

63.1

304

1026

L04AX01

ATC

azathioprine; systemic

2.1

62.2

623

2937

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

17.6

61.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

61.0

4437

33893

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

61.0

885

4737

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.4

60.6

221

632

J01AA04

ATC

lymecycline; systemic

1.5

60.6

2222

15036

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.6

60.3

206

565

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

60.1

1034

5824

J02AC01

ATC

fluconazole; systemic

1.3

60.1

6019

48177

J01CF05

ATC

flucloxacillin; systemic

1.9

59.9

853

4539

L30

ICD-10 Finland

Other dermatitis

2.5

59.9

373

1436

J01FA09

ATC

clarithromycin; systemic

1.4

59.3

4510

34663

R06.2

ICD-10 Finland

Wheezing

2.0

58.9

663

3261

L04AC05

ATC

ustekinumab; parenteral

5.1

58.7

125

239

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

58.5

1090

6278

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.3

57.9

149

333

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

57.6

H10

ICD-10 Finland

Conjunctivitis

1.6

57.0

1285

7782

H01

ICPC

Ear pain/earache

1.5

56.7

2041

13747

L21.0

ICD-10 Finland

Seborrhoea capitis

4.6

56.6

135

284

UJF32

NOMESCO Finland

Coloscopy

1.4

56.5

2576

18156

J02AB02

ATC

ketoconazole; oral

2.4

56.4

401

1642

A02BC02

ATC

pantoprazole; systemic

1.3

56.3

8656

73165

F03

ICPC

Eye discharge

1.7

56.0

1046

6028

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

56.0

3081

22447

F29

ICPC

Eye symptom/complaint other

1.6

56.0

1338

8222

L23

ICD-10 Finland

Allergic contact dermatitis

5.2

55.8

116

217

XQ801

NOMESCO Finland

Intracutantest

6.1

55.5

154

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

5.1

55.2

116

219

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.3

55.0

208

609

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

54.8

761

4015

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

54.8

2366

16500

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

54.8

8264

69570

J01AA02

ATC

doxycycline; systemic

1.3

54.6

10468

90893

J32.4

ICD-10 Finland

Chronic pansinusitis

3.1

54.5

237

755

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

54.4

593

2882

N02AX02

ATC

tramadol; systemic, rectal

1.3

54.4

4903

38527

B00.5

ICD-10 Finland

Herpesviral ocular disease

7.4

53.8

104

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

6.1

53.5

150

ZY010

NOMESCO Finland

Hospital outpatient

1.7

53.2

964

5508

L13.0

ICD-10 Finland

Dermatitis herpetiformis

7.6

53.2

J01XC01

ATC

fusidic acid; systemic

3.4

53.0

190

538

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

52.5

1854

12425

L28.2

ICD-10 Finland

Other prurigo

10.4

52.5

Z71.8

ICD-10 Finland

Other specified counselling

1.3

52.3

4792

37693

Z3226

NOMESCO Finland

Physiotherapist

1.5

52.2

2195

15221

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

51.9

2905

21194

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

51.3

1005

5863

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.4

51.3

185

526

V01AA05

ATC

tree pollen; parenteral

3.2

51.3

202

607

R74

ICPC

Upper respiratory infection acute

1.3

51.2

6095

49618

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

51.2

2825

20553

D11AH04

ATC

alitretinoin; oral

133.2

51.1

L71.8

ICD-10 Finland

Other rosacea

3.0

50.8

227

735

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.7

50.7

278

1005

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.3

50.6

401

1721

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

50.4

2556

18323

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

49.8

6349

52084

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

49.3

R05

ICD-10 Finland

Cough

1.4

49.0

2733

19903

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.6

48.8

289

1086

R03BC03

ATC

nedocromil; inhalant

1.8

48.6

778

4288

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

10.2

48.5

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

48.3

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.4

48.3

339

1381

R05

ICPC

Cough

1.3

48.1

3394

25644

S06

ICPC

Rash localized

1.9

48.0

681

3618

L29.8

ICD-10 Finland

Other pruritus

3.6

47.9

159

428

68409

ICD-8 Finland

Impetigo, Unspecified

11.9

47.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

47.5

3956

30620

J01AA07

ATC

tetracycline; systemic

1.4

47.4

2274

16131

R97

ICPC

Allergic rhinitis

2.2

47.3

411

1833

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

47.3

R51.80

ICD-10 Finland

Headache

1.4

47.3

2487

17924

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

47.1

2270

16113

D07XB02

ATC

triamcinolone; topical

3.3

46.4

174

507

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

46.4

1540

10175

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.3

46.4

359

1526

S18

ICPC

Laceration/cut

1.3

46.3

5295

42731

J20

ICD-10 Finland

Acute bronchitis

1.6

45.7

1317

8438

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

45.7

1098

6744

69200

ICD-8 Finland

Other eczema and dermatitis, Due to detergents

17.5

45.5

D05AA

ATC

Tars

5.1

45.3

183

T78.3

ICD-10 Finland

Angioneurotic oedema

3.1

45.1

188

585

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

44.7

1097

6774

Z2221

NOMESCO Finland

Medical doctor

1.3

44.5

3728

28832

J01DB05

ATC

cefadroxil; oral

1.9

44.4

583

3020

SPAT1058

SPAT

PEF monitoring instruction

1.7

44.4

937

5573

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

44.2

L71.9

ICD-10 Finland

Rosacea, unspecified

2.3

44.1

325

1353

ZXE00

NOMESCO Finland

One hour or less

1.3

44.0

5253

42554

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

44.0

1649

11160

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

43.8

1289

8295

R03DC01

ATC

zafirlukast; oral

3.2

43.7

179

551

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.7

43.3

101

209

R50.9

ICD-10 Finland

Fever, unspecified

1.4

43.3

1957

13718

69109

ICD-8 Finland

Infantile eczema and related conditions, Unspecified

+∞

43.2

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

42.9

4593

36676

XQ820

NOMESCO Finland

Exposure to medicinal substance

5.7

42.7

136

R53

ICD-10 Finland

Malaise and fatigue

1.3

42.3

3232

24647

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

42.1

676

3728

D07XB01

ATC

flumetasone; topical

5.0

42.0

177

J33.8

ICD-10 Finland

Other polyp of sinus

2.6

41.9

244

910

L71.0

ICD-10 Finland

Perioral dermatitis

2.3

41.9

314

1317

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

41.5

410

1923

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

41.5

539

2783

V01AA02

ATC

grass pollen; parenteral

4.1

41.4

115

273

WXQ24

NOMESCO Finland

UVB/UVA light therapy

66.3

41.3

S01

ICPC

Pain/tenderness of skin

1.9

41.1

552

2881

J01DA06

ATC

[U] cefuroxime

1.4

41.0

1751

12141

M54.5

ICD-10 Finland

Low back pain

1.3

40.8

4991

40458

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

12.9

40.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

40.6

3308

25432

Z2446

NOMESCO Finland

Social worker

1.6

40.4

958

5862

ZXA10

NOMESCO Finland

Bilateral

1.4

39.3

1910

13548

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

39.1

11861

106334

L04AC10

ATC

secukinumab; parenteral

4.4

38.9

220

N03AX16

ATC

[U] pregabalin

1.4

38.8

2439

18035

L04AC18

ATC

risankizumab; parenteral

7.1

38.8

N02BE01

ATC

paracetamol; systemic, rectal

1.3

38.7

13084

118772

A07AA02

ATC

nystatin; oral

1.9

38.6

528

2771

R21

ICPC

Throat symptom/complaint

1.3

38.3

4175

33314

D07AB10

ATC

alclometasone; topical

5.2

37.9

145

L12

ICPC

Hand/finger symptom/complaint

1.4

37.8

2265

16618

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

37.8

4559

36817

D01AC02

ATC

miconazole; topical

1.7

37.8

713

4115

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

37.4

1124

7262

F73

ICPC

Eye infection/inflammation other

2.2

37.3

316

1396

N06AX11

ATC

mirtazapine; oral

1.3

37.3

4374

35196

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

37.3

314

1384

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

37.1

876

5355

6840A

ICD-9 Finland

Impetigo[IMPETIGO CONTAGIOSA]

10.4

36.6

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

4.0

36.5

105

256

H02AB09

ATC

hydrocortisone; systemic

2.1

36.3

340

1563

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

36.2

422

2102

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

36.1

2019

14643

J04BA02

ATC

dapsone; oral

4.7

36.1

170

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

7.2

36.0

S99

ICPC

Skin disease other

2.5

35.7

224

867

L16

ICPC

Ankle symptom/complaint

1.4

35.4

1624

11388

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

35.3

11468

102838

L01BA01

ATC

methotrexate; systemic

2.0

35.1

399

1969

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

35.1

3812

30345

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.3

34.9

134

397

SPAT1267

SPAT

Desensitisation

5.4

34.8

124

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

34.6

5309

43974

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

34.5

788

4777

S01AA01

ATC

chloramphenicol; ophthalmic

1.7

34.3

652

3769

R4110

NOMESCO Finland

Physiotherapy

1.3

34.3

3097

24073

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

8.4

34.2

50709

ICD-8 Finland

Hay fever, Unspecified

4.3

34.1

198

A02BC05

ATC

esomeprazole; systemic

1.2

34.1

4720

38639

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.4

33.9

227

906

J01CA04

ATC

amoxicillin; systemic

1.3

33.9

13464

123193

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

33.9

4086

32912

D11

ICPC

Diarrhoea

1.4

33.9

1894

13729

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

33.9

246

1019

A04

ICPC

Weakness/tiredness general

1.4

33.8

2043

14990

M79.1

ICD-10 Finland

Myalgia

1.4

33.8

1978

14440

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.8

33.8

169

584

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

33.7

175

617

A02BC01

ATC

omeprazole; systemic

1.3

33.4

3009

23370

L85.3

ICD-10 Finland

Xerosis cutis

3.3

33.2

125

366

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

33.1

2610

19906

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

33.0

4299

34917

Z01.2

ICD-10 Finland

Dental examination

1.2

32.5

7316

62928

G44.2

ICD-10 Finland

Tension-type headache

1.4

32.5

1930

14117

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

32.4

350

1698

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

32.3

2155

16042

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

32.3

474

2544

J01MA14

ATC

moxifloxacin; systemic

1.6

32.3

863

5428

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

32.0

3117

24440

L01

ICPC

Neck symptom/complaint

1.3

31.7

2123

15811

B07.9

ICD-10 Finland

Verruca simplex

1.8

31.6

531

2968

R42

ICD-10 Finland

Dizziness and giddiness

1.3

31.5

2295

17299

WX002

NOMESCO Finland

Sedation and analgesia

1.4

31.5

1878

13742

N06AX21

ATC

duloxetine; oral

1.4

31.4

1449

10165

X58

ICD-10 Finland

Exposure to other specified factors

1.4

31.4

1932

14207

N01

ICPC

Headache

1.3

31.3

2200

16496

SPAT1260

SPAT

Consultation of another employee

1.3

31.3

2098

15623

A03

ICPC

Fever

1.3

31.3

2973

23223

L04AC13

ATC

ixekizumab; parenteral

5.0

31.2

133

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

31.1

456

2448

L03

ICPC

Low back symptom/complaint

1.3

30.7

3742

30124

H18.6

ICD-10 Finland

Keratoconus

3.5

30.4

104

287

H60.8

ICD-10 Finland

Other otitis externa

1.9

30.3

385

1975

J01MA12

ATC

levofloxacin; systemic

1.4

30.3

1662

11999

N06AB06

ATC

sertraline; oral

1.4

30.3

1724

12520

J01MA02

ATC

ciprofloxacin; systemic

1.2

30.2

4118

33554

L04AB04

ATC

adalimumab; parenteral

2.0

30.2

326

1582

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

30.0

407

2133

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

3.8

30.0

227

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

5.0

29.9

127

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

29.9

3216

25497

L04AC16

ATC

guselkumab; systemic

6.2

29.6

Y1202

ICD-8 Finland

Skin tests, Allergy tests

7.2

29.5

N06AA12

ATC

doxepin; systemic

1.8

29.5

431

2312

R60.0

ICD-10 Finland

Localized oedema

1.5

29.3

1028

6851

RS340, ,

NOMESCO Finland

5.7

29.2

N03AX12

ATC

[U] gabapentin; oral

1.4

29.2

1666

12100

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

6.7

29.1

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

5.2

28.9

109

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

28.8

678

4138

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

28.8

872

5635

N05AH04

ATC

quetiapine; oral

1.3

28.7

2581

19997

S91

ICPC

Psoriasis

3.2

28.7

114

346

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

28.6

817

5216

K02.1

ICD-10 Finland

Caries of dentine

1.2

28.6

9624

85560

Z01.7

ICD-10 Finland

Laboratory examination

1.3

28.4

1812

13381

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

28.4

11260

101626

SPAT1312

SPAT

General health counselling

1.2

28.4

4777

39748

ZXA05

NOMESCO Finland

Left side

1.3

28.4

2237

17028

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

28.3

1075

7274

R83

ICPC

Respiratory infection other

1.2

28.2

4750

39522

WQ064, ,

NOMESCO Finland

145.1

28.2

S01AA13

ATC

fusidic acid; ophthalmic

1.8

28.2

469

2614

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

28.1

6306

53965

ZX112

NOMESCO Finland

Subcutaneous

2.3

28.1

221

949

L40

ICD-10 Finland

Psoriasis

2.3

28.0

219

938

B00.0

ICD-10 Finland

Eczema herpeticum

3.4

27.9

280

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.9

27.8

130

434

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

27.6

1386

9853

R4190

NOMESCO Finland

Nutritional therapy

1.7

27.6

550

3222

H29

ICPC

Ear symptom/complaint other

1.4

27.5

1215

8449

C03CA01

ATC

furosemide; systemic

1.3

27.5

1723

12691

RJ411, ,

NOMESCO Finland

4.1

27.4

177

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

96.7

27.2

B00.11

ICD-10 Finland

Herpes simplex labialis

2.1

27.2

258

1194

M79.7

ICD-10 Finland

Fibromyalgia

1.7

27.1

457

2556

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

27.1

1453

10440

SPAT1283

SPAT

Restricted health certificate

1.2

27.1

3608

29267

SPAT1254

SPAT

Administration of medicine

1.3

27.0

1794

13323

M01AE02

ATC

naproxen; oral, rectal

1.2

27.0

8522

75127

N05BA04

ATC

oxazepam; oral

1.3

26.9

3209

25706

F02

ICPC

Red eye

1.6

26.9

562

3333

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.2

26.8

105

316

SFA10

NOMESCO Finland

One-surface restoration

1.2

26.8

8611

76014

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

26.8

1753

12993

G47.3

ICD-10 Finland

Sleep apnoea

1.3

26.7

2322

17896

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

26.6

5013

42121

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

26.4

275

1318

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.3

26.4

2130

16257

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

30.8

26.3

S01XA02

ATC

retinol; ophthalmic

5.1

26.3

104

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.2

26.3

103

310

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

2.5

26.3

161

618

L60.0

ICD-10 Finland

Ingrowing nail

1.6

26.2

574

3443

D07AC09

ATC

budesonide; topical

7.9

26.1

L30.4

ICD-10 Finland

Erythema intertrigo

2.9

26.1

122

407

L15

ICPC

Knee symptom/complaint

1.3

26.1

2787

22031

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

26.0

1064

7300

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

25.9

2178

16708

S84

ICPC

Impetigo

2.8

25.9

126

430

N06AB03

ATC

fluoxetine; oral

1.4

25.9

1522

11097

C84.0

ICD-10 Finland

Mycosis fungoides

28.2

25.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

25.7

932

6246

K90.0

ICD-10 Finland

Coeliac disease

1.8

25.7

367

1955

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

25.7

5547

47178

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

25.7

7024

61031

L73.8

ICD-10 Finland

Other specified follicular disorders

2.8

25.6

128

443

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

25.5

2294

17753

A07EB01

ATC

cromoglicic acid; oral

9.7

25.4

R52.9

ICD-10 Finland

Pain, unspecified

1.4

25.3

1120

7791

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

25.3

962

6510

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.2

25.3

204

886

R01AD59

ATC

mometasone, combinations; nasal

1.6

25.2

632

3916

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

25.2

3365

27268

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

25.2

1180

8288

R07.0

ICD-10 Finland

Pain in throat

1.4

25.2

1114

7749

P01

ICPC

Feeling anxious/nervous/tense

1.3

25.1

2562

20131

A02BC03

ATC

lansoprazole; oral

1.3

25.0

2751

21807

N06AB04

ATC

citalopram; systemic

1.3

25.0

2402

18734

S01XA18

ATC

ciclosporin; ophthalmic

3.2

25.0

300

SPAT1301

SPAT

No procedures

1.2

25.0

3853

31694

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

25.0

339

1778

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

24.9

604

3714

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

24.9

3305

26764

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

24.8

2132

16395

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

24.8

765

4965

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

24.7

224

1020

H60

ICD-10 Finland

Otitis externa

1.5

24.5

701

4475

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

24.5

997

6830

EMB30

NOMESCO Finland

Adenotomy

1.5

24.5

697

4446

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

24.4

764

4972

S06.0

ICD-10 Finland

Concussion

1.4

24.3

1367

9893

Z00.1

ICD-10 Finland

Routine child health examination

1.4

24.3

1018

7011

N06BA04

ATC

methylphenidate; oral

1.5

24.2

709

4549

L50.1

ICD-10 Finland

Idiopathic urticaria

2.9

24.2

117

398

J01DA08

ATC

[U] cefaclor

1.3

24.2

2112

16271

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

24.2

1126

7900

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.1

24.1

307

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

24.0

982

6732

SPAT1310

SPAT

Counselling related to known health issue

1.2

24.0

4231

35246

L50.5

ICD-10 Finland

Cholinergic urticaria

7.6

24.0

D01AE15

ATC

terbinafine; topical

1.6

23.9

610

3795

R03DX09

ATC

mepolizumab; parenteral

9.3

23.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

23.9

221

1014

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

5.1

23.8

R29

ICPC

Respiratory symptom/complaint other

1.5

23.7

816

5414

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

23.7

391

2175

Z00.0

ICD-10 Finland

General medical examination

1.3

23.7

2405

18873

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.3

23.7

266

A07EC02

ATC

mesalazine; oral, rectal

1.5

23.6

646

4085

S97

ICPC

Chronic ulcer skin

1.7

23.6

410

2315

L70.0

ICD-10 Finland

Acne vulgaris

1.5

23.5

673

4298

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

23.4

1049

7311

K50.8

ICD-10 Finland

Other Crohn disease

2.1

23.4

210

953

E000008, ,

ATC

4.0

23.3

164

D07AC04

ATC

fluocinolone acetonide; topical

7.9

23.3

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.2

23.3

203

910

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

23.2

5509

47148

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

23.1

1859

14163

P01AB01

ATC

metronidazole; oral, rectal

1.2

23.1

5231

44570

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

23.1

228

1072

P29

ICPC

Psychological sympt/compl other

1.4

22.8

1271

9182

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

6.0

22.8

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.8

22.7

176

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

22.7

793

5279

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

22.7

300

1562

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

22.6

871

5906

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.9

22.6

271

1366

L40.4

ICD-10 Finland

Guttate psoriasis

3.5

22.6

208

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

22.6

1027

7177

3028

Kela drug reimbursment

Mepolizumab

9.0

22.5

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

22.4

399

2268

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.3

22.4

174

744

-1, ,

NOMESCO Finland

1.2

22.4

5436

46570

N06AB10

ATC

escitalopram; oral

1.2

22.4

3238

26417

H16.0

ICD-10 Finland

Corneal ulcer

1.6

22.4

590

3700

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

22.4

1285

9327

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

22.3

1932

14862

RJ420, ,

NOMESCO Finland

4.3

22.3

128

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.3

22.2

160

663

N06AX16

ATC

venlafaxine; oral

1.3

22.2

2005

15506

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

22.1

261

1309

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.0

21.9

234

1133

OAA40, ,

SPAT

1.8

21.9

322

1733

DPA30

NOMESCO Finland

Sphenotomy

3.2

21.9

260

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

26.4

21.8

M03BX02

ATC

tizanidine; oral

1.2

21.8

8605

76676

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.5

21.8

135

522

A07EA06

ATC

budesonide; oral, local oral

1.7

21.8

443

2610

J04.0

ICD-10 Finland

Acute laryngitis

1.5

21.8

617

3933

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

21.7

245

1209

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

21.7

1052

7429

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

21.6

1034

7285

B02.9

ICD-10 Finland

Zoster without complication

1.6

21.6

519

3186

RD210, ,

NOMESCO Finland

1.9

21.5

268

1368

M10.9

ICD-10 Finland

Gout, unspecified

1.7

21.5

388

2215

J01

ICD-10 Finland

Acute sinusitis

1.5

21.5

789

5303

SPAT1263

SPAT

Sampling

1.2

21.4

5799

50088

H57.1

ICD-10 Finland

Ocular pain

1.6

21.4

489

2967

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

21.3

5413

46497

A02BA02

ATC

ranitidine; systemic

1.3

21.3

1583

11925

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

21.3

1603

12098

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

21.2

543

3382

J01CF02

ATC

cloxacillin; systemic

2.1

21.0

188

853

D01

ICPC

Abdominal pain/cramps general

1.3

20.9

1772

13584

D07BB01

ATC

flumetasone and antiseptics; topical

3.6

20.9

182

S01AA02

ATC

chlortetracycline; ophthalmic

3.4

20.9

205

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

20.9

489

2984

L50.2

ICD-10 Finland

Urticaria due to cold and heat

3.8

20.8

156

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

20.8

279

1459

13300, ,

ICD-8 Finland

4.6

20.8

103

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

20.8

568

3592

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

32.6

20.7

SBB10

NOMESCO Finland

Dental impressions

1.4

20.7

1212

8823

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

20.7

1106

7938

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.9

20.6

246

1238

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.5

20.6

202

XQ845

NOMESCO Finland

Dermatoscopy

2.5

20.6

134

530

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

20.6

2924

23784

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

20.5

1031

7324

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.3

20.5

158

674

A01AB09

ATC

miconazole; local oral

1.4

20.5

855

5882

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

20.5

520

3233

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

20.5

515

3197

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

20.4

1509

11358

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.6

20.4

465

2821

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

20.3

688

4551

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

20.3

890

6179

N05CF01

ATC

zopiclone; oral

1.2

20.2

3134

25711

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

20.2

789

5363

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

20.2

5022

43017

ZXA00

NOMESCO Finland

Right side

1.2

20.2

2353

18738

R03BB01

ATC

ipratropium bromide; inhalant

2.0

20.1

224

1102

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

8.2

20.1

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

20.0

563

3582

X57

ICD-10 Finland

Unspecified privation

1.9

20.0

242

1224

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.8

20.0

102

358

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

20.0

1057

7572

R06AX25

ATC

mizolastine; oral

4.0

20.0

135

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

19.9

1296

9580

N05BA01

ATC

diazepam; systemic, rectal

1.3

19.9

1267

9335

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.6

19.9

118

447

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.5

19.9

569

3634

R11

ICD-10 Finland

Nausea and vomiting

1.4

19.9

1054

7553

C07AB07

ATC

bisoprolol; oral

1.2

19.9

3993

33568

ZXD05

NOMESCO Finland

Urgent procedure

1.2

19.9

3873

32470

H92.0

ICD-10 Finland

Otalgia

1.4

19.8

874

6072

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.2

19.8

168

746

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

19.7

216

1056

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

19.7

226

1124

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

19.6

417

2485

SPAT1240

SPAT

Therapeutic discussion

1.3

19.6

1830

14192

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

19.6

1158

8437

49308

ICD-8 Finland

Asthma, Alia definita

4.9

19.6

D82

ICPC

Teeth/gum disease

1.2

19.6

5800

50366

50702

ICD-8 Finland

Hay fever, Aestivalis

16.7

19.5

R03CC03

ATC

terbutaline; systemic

1.6

19.5

477

2942

M01AC05

ATC

lornoxicam; systemic, rectal

20.0

19.5

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

20.0

19.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

19.5

919

6460

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

6.9

19.4

AA1AD

NOMESCO Finland

CT of head and brain

1.2

19.4

2235

17771

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

19.3

8009

71340

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

19.3

934

6595

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

19.3

8929

80194

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

19.2

1229

9060

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

19.2

908

6386

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

19.2

5333

46054

SPAT1316

SPAT

Extensive health check-up of children and adolescents

1.3

19.2

1406

10569

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.8

19.2

318

A05

ICPC

Feeling ill

1.3

19.1

1143

8345

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

19.1

728

4928

1200, ,

NOMESCO Finland

6.5

19.0

R03AC04

ATC

fenoterol; inhalant

4.6

19.0

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

19.0

237

1213

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

18.9

437

2661

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

44.4

18.9

E66.8

ICD-10 Finland

Other obesity

1.4

18.8

739

5028

R13

ICD-10 Finland

Dysphagia

1.5

18.8

566

3654

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

18.8

544

3483

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

18.8

1999

15743

F45.8

ICD-10 Finland

Other somatoform disorders

1.3

18.7

1124

8210

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

18.7

538

3441

QXA70

NOMESCO Finland

Guidance related to rash and skin care

17.5

18.7

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

18.6

2301

18424

WW200

NOMESCO Finland

Immunization

1.8

18.6

300

1661

L03.2

ICD-10 Finland

Cellulitis of face

2.7

18.6

101

367

A12

ICPC

ALLERGY/ALLERGIC REACTION

3.3

18.6

202

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.9

18.5

287

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

33.1

18.5

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

18.5

762

5230

L02

ICPC

Back symptom/complaint

1.3

18.5

1385

10440

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

18.5

1815

14161

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

18.4

532

3405

C07AA05

ATC

propranolol; systemic

1.2

18.4

2787

22788

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

18.4

1124

8230

RS221, ,

NOMESCO Finland

2.1

18.4

170

782

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

4.3

18.3

106

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.6

18.3

386

2299

UDM02

NOMESCO Finland

Sinoscopy

1.9

18.2

234

1208

L28

ICPC

Limited function/disability (L)

1.3

18.2

1306

9786

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.3

18.1

1168

8619

SCA02

NOMESCO Finland

Preventive oral health care

1.3

18.1

1837

14382

XG430

NOMESCO Finland

Spiroegometry

3.5

18.1

172

N05CD07

ATC

temazepam; oral

1.4

18.1

740

5073

3029

Kela drug reimbursment

Upadacitinib

4.2

18.1

111

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

18.1

2928

24094

SPAT1325

SPAT

Vaccination

1.2

18.1

3759

31653

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

5.2

18.0

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.0

18.0

193

937

L29.2

ICD-10 Finland

Pruritus vulvae

2.1

18.0

175

820

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

4.0

18.0

124

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

18.0

1503

11491

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.5

18.0

107

407

W19

ICD-10 Finland

Unspecified fall

1.4

17.9

1025

7432

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

17.9

378

2251

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

5.3

17.9

C09CA06

ATC

candesartan; oral

1.2

17.8

2416

19531

L63.9

ICD-10 Finland

Alopecia areata, unspecified

2.7

17.8

353

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

20.9

17.8

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

17.7

2298

18487

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

17.7

1019

7394

N76.0

ICD-10 Finland

Acute vaginitis

1.3

17.7

1154

8530

Z2445

NOMESCO Finland

Psychologist

1.5

17.7

650

4369

S01AX11

ATC

[U] ofloxacin

1.7

17.7

294

1642

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

4.8

17.6

QXA70, ,

SPAT

1.8

17.5

261

1412

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.2

17.5

143

626

SFA30

NOMESCO Finland

Three-surface restoration

1.2

17.5

5222

45261

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

17.3

741

5123

H26.3

ICD-10 Finland

Drug-induced cataract

3.1

17.3

221

R51

ICD-10 Finland

Headache

1.4

17.3

816

5737

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

17.3

686

4679

B86

ICD-10 Finland

Scabies

1.6

17.3

389

2354

9700/3-C44.9

ICD-O-3

Mycosis fungoides of skin, NOS

173.9

17.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

17.2

419

2582

EMB10

NOMESCO Finland

Tonsillectomy

1.3

17.2

1035

7561

WX290

NOMESCO Finland

Other blockage of nerve

1.2

17.2

7816

69843

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

17.2

131

558

49309

ICD-8 Finland

Asthma, Unspecified

5.2

17.1

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

5.2

17.1

M04AA01

ATC

allopurinol; systemic

1.4

17.1

693

4743

P74

ICPC

Anxiety disorder/anxiety state

1.4

17.1

754

5239

H60.1

ICD-10 Finland

Cellulitis of external ear

2.1

17.1

161

746

SFA20

NOMESCO Finland

Two-surface restoration

1.2

17.1

8888

80165

XX9XT

NOMESCO Finland

Other radiological intervention

15.0

17.1

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.2

17.0

149

671

B08.4

ICD-10 Finland

Enteroviral vesicular stomatitis with exanthem

2.4

17.0

119

488

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

17.0

657

4459

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

17.0

137

597

D05AC01

ATC

dithranol; topical

12.6

17.0

R52.2

ICD-10 Finland

Other chronic pain

1.6

16.9

368

2208

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

16.9

273

1513

S09

ICPC

Infected finger/toe

1.7

16.9

334

1956

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

16.9

1128

8366

L14

ICPC

Leg/thigh symptom/complaint

1.4

16.9

790

5546

K30

ICD-10 Finland

Functional dyspepsia

1.3

16.8

1268

9566

L56.4

ICD-10 Finland

Polymorphous light eruption

3.5

16.8

153

L04AA44

ATC

[U] upadacitinib

4.5

16.8

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.9

16.8

122

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

16.8

852

6064

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

5.5

16.7

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.0

16.7

175

844

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

16.7

192

957

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

16.7

1048

7706

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

16.6

3751

31764

L63.8

ICD-10 Finland

Other alopecia areata

3.3

16.6

182

P03

ICPC

Feeling depressed

1.2

16.6

1827

14431

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

16.6

603

4046

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.4

16.6

173

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

16.5

1423

10924

S80.0

ICD-10 Finland

Contusion of knee

1.3

16.5

959

6973

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

16.4

1194

8963

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

16.4

2583

21181

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.3

16.3

120

503

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.6

16.3

402

2485

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

16.3

4289

36766

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

16.3

1251

9456

UKC02

NOMESCO Finland

Cystoscopy

1.3

16.3

1040

7665

SDA03

NOMESCO Finland

Periodontal treatment

1.2

16.3

5727

50187

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.8

16.2

221

1164

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.5

16.2

472

3028

N03AX09

ATC

lamotrigine; oral

1.4

16.2

723

5034

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

16.2

228

1214

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

1.9

16.1

205

1057

07900

ICD-8 Finland

Other viral diseases, Molluscum contagiosum

5.8

16.0

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.6

15.9

355

2144

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

15.9

535

3536

N30.0

ICD-10 Finland

Acute cystitis

1.2

15.9

1987

15913

ZXD20

NOMESCO Finland

Day surgery

1.3

15.9

1379

10591

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

15.9

621

4226

A98

ICPC

Health maint/preventive medicine

1.5

15.8

16134

153495

49099

ICD-8 Finland

Bronchitis, unspecified

2.4

15.8

107

433

SPAT1059

SPAT

Spirometry at the office

1.5

15.8

429

2713

L11

ICPC

Wrist symptom/complaint

1.3

15.8

1227

9293

A06AD11

ATC

lactulose; oral

1.3

15.8

1027

7591

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

15.7

619

4217

F01

ICPC

Eye pain

1.6

15.7

365

2227

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.1

15.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.6

2361

19273

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.5

15.6

497

3251

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

15.6

548

3655

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

15.6

371

2277

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

15.6

659

4549

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.5

15.5

378

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

1.8

15.5

246

1357

A07EA02

ATC

hydrocortisone; rectal

1.8

15.5

226

1217

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

15.5

880

6375

D19

ICPC

Teeth/gum symptom/complaint

1.2

15.5

4154

35641

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

15.4

593

4021

6924B

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E METALLIS ALLERGICA]

+∞

15.4

6925B

ICD-9 Finland

Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFACTA EX ALIMENTIS ALLERGICA,VÄLITÖN]

+∞

15.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

15.4

543

3623

S07

ICPC

Rash generalized

2.7

15.4

285

L09

ICPC

Arm symptom/complaint

1.4

15.3

566

3810

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.8

15.3

117

H60.3

ICD-10 Finland

Other infective otitis externa

1.7

15.3

252

1406

120

Kela drug reimbursment

Hypogammaglobulinaemia

4.5

15.2

H70

ICPC

Otitis externa

1.8

15.2

244

1352

A28

ICPC

Limited function/disability NOS

1.3

15.2

963

7091

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

15.1

378

2346

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

15.1

1403

10862

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

15.1

5054

44065

N06AA09

ATC

amitriptyline; systemic

1.4

15.1

747

5294

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

1.7

15.1

257

1448

H10.2

ICD-10 Finland

Other acute conjunctivitis

1.9

15.1

180

910

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

15.0

995

7370

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

1.8

15.0

208

1102

H03.1*B02.3

ICD-10 Finland

Zoster blepharitis

3.9

15.0

110

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

5.3

14.9

L10

ICPC

Elbow symptom/complaint

1.4

14.9

641

4436

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1130

3234

3.55

312.47

1.2

1.1

4.16

1.99

u/ml

6.52

832

1558

(3005322) IgE [Units/volume] in Serum or Plasma

2722

8277

3.60

307.65

1.6

1.3

992.12

135.17

u/ml

30.87

2591

7629

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1258

3742

3.43

307.65

1.2

1.1

3.56

2.34

u/ml

2.43

853

1843

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

320

236

13.33

307.65

1.2

1.1

10.39

2.01

u/ml

2.58

256

154

(3003888) Timothy IgE Ab [Units/volume] in Serum

1168

3305

3.59

307.65

1.2

1.1

7.79

6.42

u/ml

1.58

845

1697

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1089

3176

3.47

292.11

1.2

1.1

2.52

0.91

u/ml

5.80

718

1315

(3013115) Eosinophils [#/volume] in Blood

9025

63847

1.79

285.03

7.3

6.0

0.24

0.18

e9/l

104.64

8119

56809

(3001604) Monocytes [#/volume] in Blood

8741

61502

1.78

278.75

7.1

5.7

0.57

0.55

e9/l

11.31

7776

53914

(3006315) Basophils [#/volume] in Blood

8752

61605

1.78

278.67

7.1

5.7

0.04

e9/l

13.72

7774

53921

(40760892) CBC W Ordered Manual Differential panel - Blood

8347

57985

1.78

277.73

7.5

6.2

—

(3019198) Lymphocytes [#/volume] in Blood

8998

64280

1.76

267.93

7.0

5.7

2.00

e9/l

0.17

8168

57752

(40768443) Skin Pathology biopsy report

1072

3284

3.30

265.44

1.3

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

353

438

7.93

252.64

1.2

1.1

27.99

2.46

u/ml

0.70

275

252

(3006504) Eosinophils/100 leukocytes in Blood

8243

58142

1.73

249.98

7.0

5.8

3.46

2.75

103.35

7835

54756

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

204

109

18.28

249.35

1.0

0.25

0.11

u/ml

0.70

135

(3019069) Monocytes/100 leukocytes in Blood

8277

58492

1.73

248.90

7.3

6.1

8.27

8.14

4.06

7891

55199

(3022096) Basophils/100 leukocytes in Blood

7984

56037

1.72

244.57

7.1

5.9

0.70

0.67

5.36

7568

52536

(3018010) Neutrophils/100 leukocytes in Blood

8418

60343

1.70

235.05

6.8

5.6

55.59

55.97

2.41

8041

57091

(3002030) Lymphocytes/100 leukocytes in Blood

8512

61261

1.70

233.59

7.1

5.8

29.38

29.93

5.34

8130

58003

(3013650) Neutrophils [#/volume] in Blood by Automated count

9540

70977

1.70

229.32

9.1

8.5

3.98

3.97

e9/l

0.20

8490

62145

(3027231) Wheat IgE Ab [Units/volume] in Serum

266

260

10.02

229.00

1.2

1.0

8.71

0.66

u/ml

1.43

243

236

(3011841) English Walnut IgE Ab [Units/volume] in Serum

199

127

15.30

222.78

1.1

1.0

5.05

0.60

u/ml

1.24

170

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

192

117

16.01

220.14

1.1

1.0

4.69

0.23

u/ml

2.88

160

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

159

22.45

212.33

1.0

1.74

0.16

u/ml

1.63

111

(3014133) Dog dander IgE Ab [Units/volume] in Serum

876

2767

3.17

205.26

1.1

10.06

3.38

u/ml

10.62

618

1287

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

194

153

12.37

192.49

1.3

31.25

72.50

titre

1.09

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

216

202

10.44

191.78

1.4

1.3

25.26

19.23

u/ml

0.55

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

196

160

11.95

190.35

1.3

696.25

250.00

titre

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

175

127

13.43

182.44

1.0

3.18

0.63

u/ml

0.68

101

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

174

130

13.05

178.34

1.0

0.93

0.09

u/ml

1.08

112

(3007853) Bacteria identified in Skin by Aerobe culture

2445

13090

1.94

176.73

1.8

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

786

2596

3.02

170.12

1.1

9.88

5.06

u/ml

5.94

518

1049

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

139

18.03

169.02

1.5

1.0

11.34

0.11

u/ml

1.88

127

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

160

121

12.88

162.80

1.0

0.28

0.48

u/ml

0.27

110

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

134

16.50

156.13

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

683

2216

3.06

152.29

1.1

1.0

1.23

0.13

u/ml

5.61

361

471

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5023

34318

1.59

148.89

1.4

1.3

1.97

1.71

u/ml

0.57

1322

9619

(3020874) Milk IgE Ab [Units/volume] in Serum

442

1101

3.95

148.41

1.3

1.0

8.04

0.78

u/ml

2.83

292

297

(3013707) Erythrocyte sedimentation rate by Westergren method

11083

90262

1.55

145.98

4.2

3.5

9.88

9.49

mm/h

3.02

10418

84516

(3000494) Fungus identified in Specimen by Culture

2210

12146

1.87

145.25

1.5

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

430

1085

3.90

141.79

1.3

1.0

9.01

0.51

u/ml

2.67

267

213

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

117

17.77

141.32

1.0

29.21

9.26

u/ml

3.16

102

(3007164) IgA [Mass/volume] in Serum or Plasma

4369

29230

1.60

139.76

1.5

1.4

2.28

2.15

g/l

4.69

2663

18489

(3021589) Normoblasts [#/volume] in Blood

7402

56258

1.49

128.56

9.6

8.1

0.00

e9/l

0.20

6089

46037

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

363

890

4.00

124.53

1.3

1.2

5.02

1.72

u/ml

4.10

258

456

(3036312) Salmon IgE Ab [Units/volume] in Serum

16.12

112.94

1.1

1.0

2.86

0.01

u/ml

3.76

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

15.25

110.89

1.0

0.89

0.58

u/ml

0.24

(3015076) Soybean IgE Ab [Units/volume] in Serum

368

1023

3.53

105.28

1.1

1.0

1.24

0.44

u/ml

1.53

233

204

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

105

12.28

103.98

1.0

3.91

0.10

u/ml

1.99

(3037522) Nuclear Ab [Titer] in Serum

2774

17704

1.61

103.56

1.5

1.4

486.68

542.99

titre

0.86

557

3208

(4200892) Spirometry reversibility

1378

7258

1.91

101.28

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

268

617

4.25

100.04

1.3

1.5

5.42

7.89

ug/l

2.42

241

545

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

107

10.94

98.39

1.0

1.1

12.14

5.49

u/ml

1.66

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10542

88318

1.41

94.12

7.4

6.5

76.97

75.40

u/l

2.71

10041

83407

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6407

49545

1.40

90.18

2.5

2.3

73.88

1850.71

nmol/l

0.50

5978

46144

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

233

526

4.32

89.24

1.1

1.0

17.95

11.48

u/ml

2.49

152

329

(40758558) Short blood count panel - Blood

4212

30314

1.46

87.88

6.7

6.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

105

107

9.53

87.69

1.1

1.0

1.37

0.31

u/ml

2.67

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14712

132521

1.61

81.78

13.1

10.2

19.67

20.85

mg/l

4.48

11618

100493

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3879

27866

1.45

80.47

2.4

2.2

2.62

2.71

mg/l

2.01

3309

24090

(3048689) Calprotectin [Mass/mass] in Stool

2814

19048

1.51

78.57

2.8

2.5

128.54

115.27

ug/g

1.00

2239

15059

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

776

3693

2.08

75.64

1.8

1.18

1.17

g/l

0.49

742

3525

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

757

3572

2.10

75.48

1.8

0.23

g/l

0.18

721

3409

(36660697) Celiac disease serology panel - Serum

1926

12124

1.60

73.99

1.2

—

(3042936) Bacteria identified in Isolate by Culture

2186

14451

1.53

67.23

2.0

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11922

104272

1.36

66.73

4.3

3.9

14.38

14.44

pmol/l

1.74

11052

96482

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7909

65182

1.33

66.48

3.1

2.8

84.66

84.47

ug/l

0.03

7458

61700

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5749

45286

1.34

65.76

6.1

5.7

1.22

mmol/l

0.12

5325

41832

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

108

161

6.51

65.64

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

9.82

64.97

1.1

1.0

1.60

0.07

u/ml

0.85

(3000492) Spirometry study

2004

13101

1.54

64.69

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13506

121056

1.40

61.14

5.0

4.5

2.17

2.10

mu/l

0.09

12745

114024

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5125

40065

1.34

60.35

1.9

1.7

96.95

98.05

pmol/l

0.94

2844

21603

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6243

50358

1.31

58.51

6.5

6.2

1.22

mmol/l

0.34

5365

43121

(3023368) Bacteria identified in Blood by Culture

3315

24384

1.39

57.05

4.5

3.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

128

256

4.86

57.03

1.6

1.5

8.70

9.04

ug/l

0.39

128

256

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4949

38744

1.33

56.92

1.8

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2945

21279

1.41

56.19

1.3

8.73

10.29

u/ml

0.59

1141

8856

(3024561) Albumin [Mass/volume] in Serum or Plasma

5547

44306

1.31

54.80

5.1

4.6

36.59

36.74

g/l

1.27

5203

41331

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3060

22358

1.39

54.48

1.3

23.90

30.07

iu/ml

1.42

931

7056

(3002179) Metamyelocytes/100 leukocytes in Blood

1340

8291

1.61

54.45

4.2

3.8

0.50

0.66

2.37

374

2366

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6816

56184

1.29

52.36

5.4

5.6

10.70

10.87

umol/l

0.40

6405

52941

(3017181) Myelocytes/100 leukocytes in Blood

1426

9039

1.57

52.20

4.5

4.1

0.77

0.90

0.93

420

2692

(3021440) Promyelocytes/100 leukocytes in Blood

1373

8647

1.58

51.67

4.6

4.1

0.10

0.12

0.58

367

2307

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

255

875

2.84

51.38

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

13987

127012

1.39

50.81

13.0

10.8

3.91

3.92

mmol/l

4.38

13605

123157

(3019550) Sodium [Moles/volume] in Serum or Plasma

13948

126616

1.39

50.62

12.9

10.7

139.47

139.61

mmol/l

11.45

13599

123103

(3005719) IgG [Mass/volume] in Serum or Plasma

1433

9199

1.55

49.50

2.7

2.6

10.53

10.44

g/l

0.36

1327

8449

(3022948) Iron [Moles/volume] in Serum or Plasma

2310

16332

1.42

49.19

2.5

2.3

14.38

14.33

umol/l

0.10

2179

15394

(3025159) Blasts/100 leukocytes in Blood

1319

8321

1.58

49.18

4.7

4.1

0.28

0.23

0.07

312

1985

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1735

11690

1.48

47.55

2.3

2.1

360.91

379.13

nmol/l

3.27

1593

10806

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

176

5.29

47.28

1.0

0.02

0.05

u/ml

0.40

119

(3020961) Endomysium IgA Ab [Titer] in Serum

1248

7856

1.58

46.90

1.2

1.1

191.00

223.08

titre

0.21

224

(3026493) Urate [Moles/volume] in Serum or Plasma

3501

26728

1.33

46.00

2.5

2.3

2797.87

2888.98

umol/l

0.06

3145

24215

(3028026) IgM [Mass/volume] in Serum or Plasma

1140

7079

1.60

45.36

1.8

1.20

1.25

g/l

0.72

1069

6567

(3002385) Erythrocyte distribution width [Ratio]

13148

118807

1.32

44.84

15.4

12.5

14.18

14.68

3.63

12966

116686

(3018418) pH of Serum or Plasma

3778

29317

1.32

43.93

4.0

3.7

7.39

7.40

0.81

739

5640

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1931

13485

1.43

43.63

2.6

2.4

23.86

23.95

0.09

1703

11740

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2084

14807

1.41

42.67

2.5

2.3

2.44

2.45

g/l

0.23

1945

13792

(3037467) Urinalysis macro (dipstick) panel - Urine

9939

86953

1.26

42.49

4.4

3.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

746

4224

1.74

42.37

1.4

1.6

3.44

12.90

u/ml

4.98

142

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

732

4124

1.75

42.32

1.7

1.6

27.32

1.66

iu/ml

0.47

124

866

(3020717) Zinc [Moles/volume] in Serum or Plasma

202

681

2.89

42.12

1.7

21.47

24.98

umol/l

1.01

197

651

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

172

529

3.16

42.09

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3499

27047

1.31

41.46

1.8

1.9

0.98

1.00

mg/l

0.10

2528

19914

(3021960) Folate [Moles/volume] in Serum or Plasma

2860

21490

1.34

41.24

1.6

1.4

20.18

20.37

nmol/l

0.30

2519

18948

(3015171) Extractable nuclear Ab [Units/volume] in Serum

840

4955

1.67

41.01

1.3

1.2

0.87

0.77

u/ml

0.11

399

(3015377) Calcium [Moles/volume] in Serum or Plasma

4397

35076

1.29

40.97

2.9

3.1

2.35

mmol/l

2.02

3893

31655

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3685

28727

1.31

40.96

2.1

2.0

172.57

204.46

u/l

1.80

3488

27127

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2199

15897

1.39

40.48

3.9

0.82

mmol/l

0.06

2031

15055

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

629

3440

1.80

40.26

1.6

378.75

332.62

titre

0.11

126

(3013826) Glucose [Moles/volume] in Serum or Plasma

7730

66030

1.24

39.67

4.6

4.3

6.34

6.40

mmol/l

1.41

7063

59945

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4341

34709

1.28

39.41

2.8

2.4

55.69

62.17

u/l

1.78

4018

32189

(3031040) Bacteria [#/volume] in Urine by Automated count

9448

82574

1.24

38.96

4.4

3.7

1437.57

1526.19

e6/l

0.07

127

1003

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12971

117601

1.29

38.84

11.3

9.0

93.41

92.23

ml/min/173m2

7.84

10571

94674

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

463

2335

1.94

38.25

1.3

1.2

5.23

2.55

u/ml

0.37

160

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14841

137268

1.40

38.14

13.8

11.0

70.35

70.65

umol/l

0.66

14836

137208

(40768797) Stomach Pathology biopsy report

2005

14424

1.39

37.82

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14975

138761

1.41

37.67

10.3

8.3

26.68

26.36

u/l

0.78

14610

134549

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

560

3028

1.81

37.23

1.3

19.94

8.87

u/ml

1.13

453

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

605

3351

1.77

37.09

1.2

1.3

19.88

31.54

u/ml

0.80

212

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1802

12825

1.40

36.13

6.7

6.2

1.09

1.07

mmol/l

2.40

1694

12075

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

655

3744

1.72

35.93

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

548

2978

1.80

35.84

1.3

5.39

8.37

u/ml

0.54

293

(36304419) Bacteria [Presence] in Urine

3782

30058

1.28

35.32

3.1

2.7

—

(3007542) Rye IgE Ab [Units/volume] in Serum

7.77

35.04

1.1

1.0

30.26

0.15

u/ml

0.51

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

443

2268

1.91

35.01

1.3

1.2

23.88

23.52

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

4108

33038

1.27

34.68

3.3

2.9

63.14

73.13

e6/l

0.25

3151

24611

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2068

15158

1.36

34.51

1.8

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

133

396

3.26

34.42

1.2

108.76

108.75

0.00

119

354

(3027945) Reticulocytes/100 erythrocytes in Blood

1385

9489

1.45

34.29

3.1

2.9

1.67

1.70

0.31

1242

8549

(3018095) Leukocytes [#/volume] in Urine

4970

40940

1.24

33.86

3.8

3.3

67.58

74.43

e6/l

0.32

3419

26929

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1054

6860

1.52

33.77

1.8

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

962

6139

1.54

33.77

1.1

1.10

13.87

u/ml

1.38

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

140

436

3.12

33.64

1.2

0.30

g/l

0.39

113

345

(3030467) Casts [#/volume] in Urine by Automated count

3756

30030

1.27

33.02

3.2

2.8

0.27

0.34

e6/l

2.29

2835

22074

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12452

113005

1.25

32.76

3.9

3.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

504

2746

1.80

32.69

1.5

18.04

12.80

iu/ml

0.29

(40761511) CBC panel - Blood by Automated count

15080

140363

1.39

32.52

11.7

9.5

—

(3009261) Glucose [Presence] in Urine by Test strip

7333

63106

1.22

32.37

3.6

3.1

0.01

0.00

estimate

0.74

1489

12175

(3007700) Barley IgE Ab [Units/volume] in Serum

8.03

32.33

1.1

1.0

23.12

0.10

u/ml

0.53

(3019309) Folate [Moles/volume] in Red Blood Cells

2066

15300

1.35

32.07

1.7

1145.01

1171.93

nmol/l

0.70

1589

11990

(3000850) Epithelial cells [#/volume] in Urine

2899

22542

1.29

31.69

2.7

2.4

6.59

7.21

e6/l

1.35

2579

20070

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

947

6106

1.53

31.68

4.9

4.5

1.13

1.34

mmol/l

1.06

684

4333

(3021601) Nitrite [Presence] in Urine by Test strip

7269

62593

1.21

31.60

4.7

4.2

0.00

estimate

0.08

1541

12441

(3027135) IgG subclass 1 [Mass/volume] in Serum

282

1275

2.15

31.48

1.4

1.3

6.77

6.67

g/l

0.15

215

890

(3028192) IgG subclass 2 [Mass/volume] in Serum

282

1275

2.15

31.48

1.4

1.3

2.83

2.90

g/l

0.30

215

893

(3009343) pH of Capillary blood

970

6295

1.52

31.47

4.9

4.5

7.41

0.50

104

706

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

978

6368

1.51

31.23

4.9

4.5

5.13

5.10

kpa

0.66

925

6079

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

305

1426

2.08

31.21

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

281

1275

2.15

31.09

1.4

1.3

0.35

0.39

g/l

1.22

214

892

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5031

41820

1.23

30.80

3.3

3.1

31.87

32.01

u/l

0.04

4790

39940

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

461

2492

1.81

30.71

3.8

3.5

56.19

56.65

0.36

461

2492

(3015736) pH of Urine

6028

51064

1.22

30.61

3.2

2.9

5.94

5.96

0.23

556

5380

(4062490) Immunoglobulin typing, IgG

280

1278

2.13

30.52

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1441

10153

1.41

30.39

1.7

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

7255

62618

1.21

30.32

3.6

3.1

0.00

estimate

0.02

1549

12714

(3004588) Protein electrophoresis panel - Serum or Plasma

745

4606

1.59

30.03

1.8

2.1

—

(44813793) Dust mix specific IgE antibody measurement

248

1089

2.22

29.80

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1418

9999

1.40

29.74

1.7

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

390

2035

1.87

29.12

1.5

1.6

0.73

0.71

g/l

0.15

316

1556

(3033658) Prothrombin time (PT) actual/Normal

3586

28871

1.25

29.10

3.9

3.8

94.92

94.40

0.65

3495

28093

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4299

35327

1.24

28.95

3.0

2.7

27.52

65.32

ng/l

1.30

2161

17718

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.85

28.66

1.7

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2743

21432

1.28

28.53

1.7

1.6

—

(3007461) Platelets [#/volume] in Blood

16046

151516

1.59

28.06

19.3

15.2

267.45

260.50

e9/l

37.46

15746

148024

(3009542) Hematocrit [Volume Fraction] of Blood

16028

151344

1.57

27.56

19.3

15.3

41.08

40.63

0.47

15429

144021

(3003327) Ova and parasites identified in Stool by Light microscopy

818

5279

1.52

27.21

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

925

6132

1.48

27.02

2.2

2.4

67.14

67.01

g/l

0.22

857

5695

(3035941) MCH [Entitic mass]

16052

151672

1.58

26.90

19.1

15.1

30.05

30.02

1.72

15924

150013

(3024731) MCV [Entitic volume]

16053

151684

1.58

26.90

19.1

15.1

89.95

89.85

2.18

15924

150024

(3026361) Erythrocytes [#/volume] in Blood

16055

151711

1.58

26.84

19.2

15.2

4.54

4.55

e12/l

2.70

15727

147960

(3000963) Hemoglobin [Mass/volume] in Blood

16061

151786

1.58

26.77

19.3

15.3

135.71

135.97

g/l

1.80

15935

150126

(3010813) Leukocytes [#/volume] in Blood

16057

151740

1.58

26.77

19.2

15.2

6.91

6.68

e9/l

6.01

15737

147926

(3026782) Osmolality of Urine

2707

21282

1.27

26.58

3.0

2.5

545.25

546.81

mosm/kgh2o

0.12

2299

18237

(3000991) Gas panel - Venous blood

1182

8239

1.41

26.41

8.1

9.1

—

(3022145) Colonoscopy Study observation

1645

12144

1.34

25.74

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

7.21

25.51

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

682

4292

1.56

25.45

5.6

4.9

24.31

24.50

mmol/l

1.24

651

4087

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

818

5366

1.50

25.16

4.8

5.5

23.91

23.99

mmol/l

0.37

800

5290

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10311

92835

1.19

24.43

3.2

2.8

39.76

38.03

u/l

1.65

9799

88529

(3024354) Oxygen [Partial pressure] in Venous blood

1061

7358

1.42

24.36

4.1

4.3

4.85

4.79

kpa

0.34

1011

7129

(3023520) Reticulocytes [#/volume] in Blood

969

6613

1.44

24.31

2.7

71.04

70.62

e9/l

0.12

710

4801

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1298

9329

1.37

24.11

2.8

2.5

0.22

g/l

0.21

1211

8755

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1392

10129

1.36

23.89

4.0

4.2

241.71

234.85

u/l

0.49

1326

9647

(46235355) HIV 1 and 2 tests - Meaningful Use set

5152

43742

1.20

23.87

2.1

2.0

—

(3023419) Bacteria identified in Sputum by Culture

230

1072

2.09

23.85

3.0

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11696

106617

1.20

23.59

4.7

4.3

37.81

37.92

mmol/mol

0.63

11037

100771

(3022217) INR in Platelet poor plasma by Coagulation assay

5015

42509

1.20

23.59

9.9

9.1

1.12

1.14

inr

1.21

1594

13671

(3022313) Gas panel - Capillary blood

722

4678

1.51

23.57

5.4

4.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1611

12014

1.33

23.42

1.2

119.74

150.19

iu/ml

2.46

579

4635

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2277

17796

1.27

23.18

2.7

2.5

1.02

1.10

e6/l

0.38

1272

9483

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1232

8856

1.37

22.83

4.6

4.8

5.89

5.84

kpa

1.00

1181

8591

(3012544) pH of Venous blood

1259

9084

1.37

22.79

4.5

4.7

7.38

7.37

0.31

(3029937) Albumin [Presence] in Urine by Test strip

3986

33185

1.21

22.50

3.9

3.3

0.00

estimate

0.09

1491

12107

(3020779) Urea [Moles/volume] in Serum or Plasma

1121

7978

1.38

22.08

8.9

8.0

7.86

7.77

mmol/l

0.22

1089

7672

(3014111) Lactate [Moles/volume] in Serum or Plasma

1132

8075

1.38

21.99

6.5

7.8

1.33

1.34

mmol/l

0.08

1101

7903

(3004616) Nuclear Ab [Presence] in Serum

254

1269

1.95

21.75

1.4

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3414

28096

1.22

21.55

3.5

3.1

—

(3002032) Base excess in Venous blood by calculation

1219

8831

1.36

21.47

4.6

4.8

1.50

1.71

mmol/l

1.21

1014

7355

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12779

117824

1.20

20.98

3.8

3.5

5.65

5.67

mmol/l

1.65

11970

110119

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

158

672

2.28

20.66

1.1

17.32

10.51

u/ml

1.25

118

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

688

4537

1.48

20.63

1.1

4.05

5.03

u/ml

0.39

101

716

(3039162) Centromere protein B Ab [Units/volume] in Serum

288

1528

1.83

20.54

1.2

30.55

51.06

u/ml

0.76

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

164

715

2.23

20.22

1.3

1.2

38.29

50.65

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

385

2234

1.68

20.10

1.9

2.1

0.40

0.66

g/l

1.15

337

1980

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

320

1765

1.76

20.06

1.2

—

170.63

—

(3028626) Oxygen [Partial pressure] in Capillary blood

490

3025

1.58

19.94

5.9

5.6

9.13

9.10

kpa

0.13

465

2939

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2042

1.71

19.92

1.8

2.0

38.40

38.71

g/l

0.43

316

1838

(3023420) DNA double strand Ab [Units/volume] in Serum

263

1371

1.87

19.85

1.4

1.7

27.50

36.51

iu/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

965

6831

1.39

19.62

4.4

4.0

77.39

80.04

ng/l

0.45

852

6112

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.08

19.54

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

163

720

2.20

19.49

1.3

1.2

38.31

45.95

u/ml

0.18

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

139

575

2.34

19.41

2.8

140.76

143.06

au/ml

0.02

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1680

12925

1.28

19.20

2.8

2.9

7.51

6.97

umol/l

0.45

1438

11033

(3038026) Centromere Ab [Units/volume] in Serum

165

737

2.17

19.19

1.3

1.2

42.06

38.16

u/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

202

977

2.01

19.05

2.5

2.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2576

20835

1.23

19.01

1.6

36611219.46

28745276.79

pmol/l

0.27

2207

17958

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2468

19903

1.23

18.70

2.9

2.8

1136.50

929.65

ng/l

0.84

1970

16355

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

156

689

2.20

18.68

1.3

1.2

9.47

u/ml

0.00

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

444

2725

1.59

18.55

1.2

38.37

36.97

u/ml

0.07

235

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1126

8240

1.34

18.52

1.3

56.78

47.09

au/ml

0.64

383

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1207

8931

1.33

18.41

2.4

2.3

19.77

21.79

au/ml

0.39

857

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

146

632

2.24

18.37

3.8

3.4

7.94

8.24

mg/l

0.22

112

507

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

428

2615

1.60

18.23

1.8

2.0

7.12

7.26

g/l

1.01

386

2411

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

2612

1.59

18.10

1.8

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

293

2.84

17.87

1.2

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

2613

1.59

17.86

1.8

2.0

3.76

3.60

g/l

1.58

385

2411

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

2432

1.61

17.85

1.8

2.1

10.24

10.18

g/l

0.08

359

2221

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

322

1847

1.70

17.61

1.9

2.1

0.00

g/l

-0.00

301

1720

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2129

17013

1.24

17.49

2.6

2.7

2.42

2.43

mmol/l

0.97

1809

14805

(3044889) 12 lead EKG panel

8656

77863

1.15

17.46

3.1

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

946

6804

1.36

17.42

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

2500

1.59

17.41

1.8

2.1

2.88

2.90

g/l

0.22

366

2298

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

350

2060

1.65

17.36

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

350

2061

1.65

17.33

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

323

1865

1.69

17.25

1.9

2.1

0.01

0.00

g/l

0.35

301

1722

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3434

28823

1.19

16.95

1.6

1.41

1.37

mmol/l

1.49

3016

25025

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

346

2046

1.65

16.87

1.8

2.0

0.03

0.02

g/l

0.23

324

1896

(3009508) Creatinine [Moles/volume] in Urine

3733

31576

1.18

16.82

3.4

3.2

8.12

8.17

mmol/l

0.24

3247

27784

(3045683) HLA typing for celiac disease panel - Blood or Tissue

205

1044

1.91

16.71

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1398

10689

1.29

16.70

2.7

2.4

33.50

44.10

u/l

1.43

1204

9193

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2119

17010

1.23

16.63

2.9

2.6

3.57

3.74

e6/l

0.28

1130

8729

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

717

4967

1.41

16.56

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

235

1257

1.82

16.42

2.6

1.33

1.30

e9/l

0.19

204

1080

(3025941) Bacteria identified in Stool by Culture

1098

8147

1.32

16.40

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2474

20209

1.21

16.33

1.8

1.7

1.42

1.36

3.32

2221

18304

(40768804) Tissue Pathology biopsy report

5623

49233

1.15

16.11

2.0

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1206

9101

1.30

15.92

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

12.30

15.74

1.0

0.57

—

u/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

465

3003

1.51

15.52

1.9

2.1

11.03

10.28

mg/l

0.67

436

2824

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

661

4568

1.41

15.50

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

474

2.31

15.39

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

612

4181

1.43

15.31

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

114

484

2.28

15.11

1.2

1.1

4.22

3.49

iu/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

274

1575

1.69

14.94

1.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

3908

33463

1.17

14.82

2.8

2.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

205

1088

1.83

14.75

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1273

9769

1.28

14.74

3.2

2.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1869

14993

1.23

14.66

2.3

2.5

29.83

29.58

1.05

1809

14544

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

205

1091

1.82

14.62

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

437

2822

1.51

14.61

1.4

307.87

296.38

ug/g

0.50

233

1517

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

433

2796

1.51

14.49

1.8

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

265

1524

1.69

14.45

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

691

4871

1.39

14.44

1.9

2.0

39.73

39.48

u/l

0.13

634

4481

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

1090

1.82

14.38

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

362

2254

1.56

14.31

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

144

691

2.02

14.02

3.8

4.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3590

30657

1.17

13.97

2.3

2.1

—

(3044941) Cell count panel - Synovial fluid

239

1349

1.72

13.97

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

354

2206

1.56

13.96

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

204

1103

1.80

13.84

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1569

12427

1.24

13.84

2.4

2.3

6747.34

6407.71

u/l

0.13

623

4978

(40761535) Cells panel - Urine sediment

1035

7800

1.30

13.79

3.6

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

330

2033

1.58

13.69

1.5

1.7

10263.09

13312.52

e6/l

0.87

231

1499

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

183

961

1.85

13.66

2.4

2.8

0.21

0.23

e9/l

0.83

154

787

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

203

1101

1.79

13.64

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

203

1102

1.79

13.60

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

367

2326

1.53

13.43

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

305

1853

1.60

13.43

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

371

2360

1.53

13.35

2.5

2.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

524

3578

1.43

13.19

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1693

13588

1.23

13.16

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

229

1300

1.71

13.14

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

517

3536

1.42

12.91

1.3

1.4

112.13

114.25

titre

0.02

358

(3017958) Strawberry IgE Ab [Units/volume] in Serum

5.66

12.87

1.0

0.38

0.06

u/ml

0.58

(3024891) Influenza virus A+B Ag [Presence] in Specimen

559

3882

1.40

12.80

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

182

975

1.81

12.78

2.4

2.8

510.70

520.74

e6/l

0.12

149

788

(3017732) Neutrophils [#/volume] in Blood

1142

8808

1.27

12.68

2.1

2.4

5.87

4.38

e9/l

1.59

972

7588

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

275

1656

1.61

12.59

1.1

1.50

1.47

g/l

0.58

258

1514

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4087

35464

1.15

12.58

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1105

8497

1.27

12.58

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5539

49051

1.13

12.56

3.7

3.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

123

581

2.05

12.56

2.2

27.83

98.69

ug/l

0.79

117

553

(3019150) Specific gravity of Urine by Refractometry

3205

27356

1.16

12.35

3.7

3.2

1.02

kg/l

0.24

467

4075

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

496

3399

1.42

12.27

1.4

1.3

226.02

245.40

u/ml

1.00

303

2158

(3034770) Mitochondria Ab [Titer] in Serum

499

3427

1.42

12.20

1.3

1515.00

958.30

titre

0.58

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3908

33880

1.15

12.11

2.5

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

392

2579

1.48

12.05

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

190

1050

1.76

12.04

1.1

5.72

8.22

iu/ml

1.04

288

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

688

4991

1.34

12.04

1.6

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2174

18036

1.19

11.85

3.4

3.1

327.54

508.32

ng/l

1.01

1345

10910

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

540

3788

1.39

11.69

1.2

1.1

—

(3008898) HLA-B27 [Presence]

833

6237

1.30

11.68

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

431

2.18

11.64

2.1

1.7

135.89

142.19

au/ml

0.04

(3014765) Yersinia sp identified in Stool by Organism specific culture

543

3818

1.39

11.59

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

177

2.90

11.57

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

427

2.18

11.49

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

644

4670

1.34

11.32

2.9

2.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

543

3836

1.38

11.28

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

177

978

1.76

11.26

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

361

2378

1.48

11.06

6.3

6.0

1178.53

877.79

iu/ml

0.14

302

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

243

1469

1.61

11.02

2.9

2.6

23.09

21.98

nmol/l

0.65

230

1409

(3000060) B lymphocytes [#/volume] in Blood

114

551

2.00

10.99

2.2

2.6

243.59

247.48

e6/l

0.04

301

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

115

558

2.00

10.97

2.6

2.1

9.80

9.42

mg/l

0.32

455

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

133

3.13

10.73

1.5

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

164

2.89

10.69

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2666

22701

1.16

10.42

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

849

6477

1.28

10.33

1.5

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

188

1085

1.68

10.27

1.5

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

416

2.12

10.22

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

243

1501

1.57

10.10

1.3

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13241

124262

1.14

10.06

4.1

3.8

2.83

2.87

mmol/l

4.14

12536

117669

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

355

2380

1.45

9.98

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

376

2.16

9.96

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1994

16654

1.18

9.96

2.0

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

370

2503

1.44

9.92

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

516

3694

1.36

9.91

2.2

2.4

5.35

6.10

umol/l

0.96

387

2720

(3047007) Chlamydophila sp Ab [Presence] in Serum

356

2395

1.44

9.83

1.2

—

(3011288) Drugs identified in Urine by Screen method

966

7542

1.25

9.69

2.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1427

11600

1.21

9.69

6.0

5.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

1617

1.54

9.66

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

256

1617

1.54

9.66

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

385

2639

1.42

9.61

1.2

1.1

9.51

11.89

au/ml

0.48

193

(3021387) Prolactin [Units/volume] in Serum or Plasma

1113

8850

1.23

9.44

1.7

1.6

307.48

314.96

mu/l

0.31

999

7898

(3019225) pH of Specimen

1111

8846

1.23

9.30

4.0

3.6

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

4.83

9.08

1.0

3.51

0.14

u/ml

0.66

(3016502) Oxygen saturation in Arterial blood

1048

8315

1.23

9.08

7.4

8.2

95.92

96.15

0.55

1010

7984

(3016879) Cocaine [Presence] in Urine

1258

10169

1.21

9.06

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

775

5946

1.27

9.04

1.5

—

(3003396) Base excess in Arterial blood by calculation

1180

9489

1.22

8.96

7.0

7.7

0.74

0.80

mmol/l

0.20

953

7320

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

457

3264

1.36

8.95

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

1343

10940

1.20

8.91

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13029

122381

1.13

8.91

3.7

3.5

1.46

1.48

mmol/l

4.15

12355

116257

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1178

9477

1.22

8.91

7.0

7.7

5.07

5.06

kpa

0.08

1130

9065

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

453

3234

1.36

8.90

1.5

29.89

20.39

u/ml

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1177

9471

1.21

8.88

7.0

7.6

12.76

13.49

kpa

4.26

1126

9056

(3013005) Retinol [Moles/volume] in Serum or Plasma

133

729

1.77

8.81

2.7

2.3

1.97

1.85

umol/l

0.91

124

688

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13110

123214

1.13

8.79

3.8

3.5

4.71

4.75

mmol/l

6.72

12495

117293

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

165

961

1.66

8.78

2.4

2.7

98.01

96.97

0.16

153

887

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

150

2.77

8.76

1.7

1.24

1.82

mg/l

0.43

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1147

9222

1.22

8.73

3.0

3.5

4.63

4.61

pmol/l

0.23

1009

8360

(3028300) Cannabinoids [Presence] in Urine

1352

11047

1.20

8.68

2.1

—

(3027008) Opiates [Presence] in Urine

1349

11024

1.20

8.65

2.1

2.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

3.54

2.64

mg/l

0.30

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

2.35

2.82

mg/l

0.21

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

1.46

2.56

mg/l

1.01

101

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

1.57

1.70

mg/l

0.07

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

1.43

1.15

mg/l

0.19

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

3.20

4.15

mg/l

0.47

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

0.75

0.85

mg/l

0.12

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

146

2.78

8.62

1.6

1.7

1.69

2.14

mg/l

0.30

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

4.41

8.58

1.0

2.64

0.35

u/ml

0.88

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

278

1834

1.47

8.57

2.6

3.1

3.03

2.27

ratio

—

175

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

346

2379

1.41

8.54

1.4

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

276

1820

1.47

8.53

3.7

3.8

3717.53

5859.12

u/ml

0.15

106

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

342

2350

1.41

8.48

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

323

2198

1.43

8.45

2.0

2.1

135.37

132.55

g/l

1.27

227

1659

(3034860) Kappa light chains.free [Mass/volume] in Serum

285

1896

1.46

8.42

2.6

3.2

50.23

76.82

mg/l

0.41

217

1525

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

184

1114

1.60

8.41

1.8

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

410

2910

1.37

8.38

2.4

377.28

538.98

ug/l

0.73

357

2660

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2436

20911

1.15

8.37

2.1

2.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

394

2783

1.38

8.31

2.0

1.30

2.23

ug/l

1.51

349

2475

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

109

575

1.84

8.23

1.1

1.2

117.30

107.69

1.81

513

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

427

3060

1.36

8.22

1.5

104.82

105.43

u/ml

0.05

630

(3007456) Orange IgE Ab [Units/volume] in Serum

4.83

8.18

1.1

1.0

0.12

0.36

u/ml

0.37

(3035637) Corticotropin [Mass/volume] in Plasma

255

1675

1.48

8.06

1.5

1.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

9.09

8.06

1.0

1.1

0.25

0.03

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

153

896

1.65

8.02

1.2

—

(3013512) EKG study

3033

26482

1.13

7.99

3.1

3.0

—

(3027944) Amphetamines [Presence] in Urine

1321

10854

1.19

7.98

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

163

972

1.62

7.96

1.8

1.7

—

(40761536) Microorganisms panel - Urine sediment

1389

11466

1.18

7.95

4.0

3.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

282

1895

1.44

7.93

2.6

3.2

53.06

44.90

mg/l

0.15

217

1526

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

445

3228

1.34

7.93

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1059

8537

1.21

7.86

2.3

2.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12540

117763

1.11

7.86

3.5

3.2

1.27

1.24

mmol/l

3.54

11859

111366

(3021901) Oxygen saturation in Capillary blood

237

1547

1.49

7.75

2.7

2.9

—

(3011985) Renin [Units/volume] in Plasma

231

1500

1.49

7.75

1.6

1.7

83.34

62.36

mu/l

0.56

211

1364

(3041096) Erythrocytes [Presence] in Urine by Automated

4104

36515

1.11

7.75

3.2

2.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

368

2603

1.37

7.72

1.1

3.70

3.09

u/ml

0.36

166

1381

(3003338) MCHC [Mass/volume]

12960

121960

1.12

7.71

16.0

12.9

333.32

333.25

g/l

0.39

12868

121025

(3015235) Bicarbonate [Moles/volume] in Capillary blood

326

2261

1.40

7.70

3.3

3.6

24.57

24.20

mmol/l

1.04

319

2197

(3001964) Herpes simplex virus Ag [Presence] in Specimen

391

1.98

7.63

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

634

1.76

7.54

1.4

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

165

1002

1.60

7.51

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

430

3131

1.33

7.49

2.6

2.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1022

8252

1.21

7.47

2.5

2.3

74.42

76.11

ml/min/173m2

0.56

395

2992

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

584

4436

1.28

7.45

9.1

10.5

24.16

24.13

mmol/l

0.07

567

4332

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

545

1.81

7.43

1.1

98.23

95.16

0.44

253

(3023323) Follitropin [Units/volume] in Serum or Plasma

1319

10905

1.18

7.42

1.4

22.27

23.66

iu/l

0.90

1125

9350

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

998

1.59

7.40

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

100

532

1.82

7.39

22.8

26.6

103.78

128.65

ug/l

3.00

438

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

215

1390

1.50

7.39

1.4

1.5

810.41

488.54

pmol/l

0.30

187

1222

(3037121) Protein [Mass/volume] in Urine

495

3685

1.31

7.38

3.7

3.5

0.28

0.35

g/l

0.91

260

1710

(3004809) Band form neutrophils/100 leukocytes in Blood

222

1447

1.49

7.34

2.9

3.0

1.27

1.49

0.50

197

1307

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

609

4660

1.27

7.33

2.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

192

1215

1.53

7.31

1.5

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

226

1480

1.48

7.30

1.5

2.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

495

3692

1.30

7.28

2.3

1.9

1.46

1.38

g/l

1.07

425

3219

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

256

1721

1.44

7.23

1.7

—

(1616796) Gas panel - Central venous blood

311

2165

1.39

7.22

4.5

3.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

256

1723

1.44

7.19

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

967

7804

1.21

7.12

7.5

8.4

122.95

123.11

g/l

0.08

943

7575

(3009214) Lutropin [Units/volume] in Serum or Plasma

800

6335

1.23

7.12

1.5

1.4

9.23

9.35

u/l

0.09

633

5142

(3008757) Leukocyte morphology finding [Identifier] in Blood

165

1016

1.57

7.10

3.1

3.3

—

(3012516) Albumin [Mass/volume] in Urine

2820

24682

1.12

7.06

3.6

3.3

409.69

411.21

mg/l

0.01

1843

16025

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

257

1738

1.43

7.04

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

191

1218

1.52

7.04

1.5

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

176

1103

1.55

7.02

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

103

2.91

6.96

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

283

1957

1.40

6.86

2.6

2.2

17.46

17.07

0.86

150

934

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

214

1406

1.48

6.84

1.2

1.3

—

(40768446) Kidney Pathology biopsy report

483

1.82

6.82

1.8

1.7

—

(3003181) Sodium [Moles/volume] in Urine

201

1307

1.49

6.76

1.6

1.7

61.10

69.04

mmol/l

1.68

143

1042

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

131

773

1.64

6.74

1.8

117.26

126.85

1.21

123

735

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

303

2.04

6.71

6.4

3.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2937

25836

1.12

6.71

4.2

3.9

12.23

9.66

mg/mmol

1.31

1899

16868

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

112

636

1.70

6.67

1.6

1.4

5.53

5.99

u/l

0.48

100

540

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

460

3441

1.30

6.66

6.9

6.1

1.34

1.28

mg/l

0.94

442

3257

(3002523) Influenza virus A Ag [Presence] in Specimen

422

3123

1.31

6.61

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

128

2.64

6.60

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

559

1.75

6.59

1.0

1.1

96.66

95.12

0.26

253

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

399

1.89

6.57

1.9

1.7

0.17

0.23

nmol/l

1.04

292

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

234

1577

1.44

6.57

1.2

1.3

0.39

0.24

nmol/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

528

4028

1.27

6.56

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

421

3121

1.31

6.52

1.1

—

(3012501) Base excess in Blood by calculation

318

2268

1.36

6.42

4.7

3.4

2.26

2.23

mmol/l

0.05

202

1419

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

236

1602

1.43

6.38

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

161

1012

1.54

6.38

1.5

1.8

283.29

283.62

mosm/kgh2o

0.06

117

809

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

177

1136

1.51

6.37

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

197

1293

1.48

6.36

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

446

3347

1.29

6.32

1.4

1.5

446.20

460.51

mg/l

0.21

428

3196

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

320

2292

1.35

6.29

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

213

1424

1.45

6.26

2.5

3.3

—

(3045414) Leukocytes [Presence] in Urine

670

5283

1.23

6.25

1.8

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

137

834

1.59

6.25

1.5

32.76

36.68

0.55

531

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

781

6256

1.22

6.25

2.1

2.0

6.74

7.60

ug/l

0.53

682

5499

(3024522) Salmonella sp identified in Specimen by Organism specific culture

196

1291

1.47

6.23

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

549

1.73

6.16

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

957

7826

1.19

6.14

4.1

3.4

1.23

mmol/l

0.10

848

6858

(3025468) Yersinia sp identified in Specimen by Organism specific culture

194

1279

1.47

6.14

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

368

2702

1.32

6.13

1.6

—

(3010421) pH of Blood

357

2612

1.33

6.10

4.7

3.4

7.42

0.38

330

2373

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

537

4143

1.26

6.10

2.7

2.9

164.67

171.04

1.11

498

3938

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

194

1284

1.46

6.03

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

194

1284

1.46

6.03

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

231

1581

1.42

6.00

1.2

1.3

0.53

1.65

nmol/l

0.83

224

1531

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1399

11819

1.16

6.00

3.7

3.5

31.31

32.16

2.30

1060

8798

(1002224) Polysomnography panel

766

6152

1.21

5.98

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

123

740

1.61

5.92

1.9

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

123

740

1.61

5.92

1.9

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

123

740

1.61

5.92

1.9

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

198

1321

1.45

5.91

1.4

—

(3042631) Mycobacterium sp identified in Specimen

148

930

1.54

5.91

4.0

2.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

162

1039

1.51

5.89

1.3

237.50

200.30

titre

0.17

202

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1519

16569

0.87

5.79

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

532

4134

1.25

5.71

2.6

3.3

3.39

3.50

g/l

1.05

499

3933

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

200

1347

1.44

5.70

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

376

2802

1.30

5.67

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

188

1254

1.45

5.64

1.6

1.7

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

188

1254

1.45

5.64

1.6

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

176

2.25

5.56

3.6

3.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

806

1.56

5.54

1.1

1425.26

1421.26

miu/ml

0.01

130

806

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3201

28550

1.10

5.53

2.3

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

328

2408

1.32

5.52

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

162

1055

1.49

5.50

5.9

7.2

10.98

10.72

mg/l

0.27

154

980

(3025296) Carrot IgE Ab [Units/volume] in Serum

5.37

5.49

1.0

0.44

2.11

u/ml

—

(3044640) Blood type and Crossmatch panel - Blood

4214

38080

1.09

5.48

2.3

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

511

1.70

5.45

1.8

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

154

996

1.50

5.42

1.5

1.4

—

(3020891) Body temperature

426

3247

1.27

5.41

5.4

4.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.34

5.39

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

465

1.73

5.28

3.1

2.5

60.62

70.39

umol/l

0.18

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

158

1034

1.48

5.26

1.2

66.13

69.90

u/l

0.19

141

935

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

227

1591

1.38

5.20

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

164

1086

1.46

5.15

1.6

53.05

52.55

0.05

710

(3047352) Trisomy 18 risk [Likelihood] in Fetus

636

7365

0.83

5.15

1.5

—

(3036489) Thrombin time

627

5016

1.21

5.15

2.2

2.6

21.11

21.23

0.30

528

4258

(3023183) Ammonium ion [Moles/volume] in Plasma

282

2049

1.33

5.13

2.6

3.1

32.70

34.87

umol/l

1.13

259

1894

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

349

1.83

5.11

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1123

9455

1.16

5.08

1.4

—

(3014271) Vancomycin [Susceptibility]

262

1.96

5.03

2.9

2.6

—

(3002619) Bacteria identified in Specimen by Culture

229

2.03

5.03

1.1

—

(3005033) Fetal Nuchal fold Thickness US

636

7347

0.83

5.03

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

274

1992

1.33

4.98

4.3

2.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

172

1161

1.43

4.91

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

639

1.59

4.90

2.6

2.3

156.57

168.08

umol/l

0.14

316

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

572

1.62

4.88

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

655

7520

0.83

4.85

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

387

2958

1.27

4.85

1.4

3.63

3.60

mmol/l

0.27

366

2777

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

235

1.97

4.71

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

196

1365

1.39

4.71

3.3

31.38

26.60

mu/l

0.45

185

1277

(3026250) Tacrolimus [Mass/volume] in Blood

579

1.60

4.67

45.2

37.9

7.28

7.31

ug/l

0.05

542

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

156

1046

1.44

4.64

1.0

1.1

297.37

288.21

mg/l

0.75

146

947

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

472

1.66

4.53

1.2

1.1

14.30

19.64

u/l

0.88

432

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

206

1457

1.37

4.52

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

275

2032

1.31

4.51

3.1

4.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

474

1.65

4.46

1.2

1.1

71.81

79.82

u/l

0.68

435

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

143

2.23

4.44

1.1

17.12

22.33

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

143

2.23

4.44

1.1

12.16

35.08

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

212

1512

1.36

4.43

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

304

1.81

4.36

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

3.22

4.33

1.0

0.88

0.12

u/ml

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

164

2.12

4.31

1.5

1.6

5.67

294167.02

nmol/l

1.69

137

(3004119) Hemoglobin [Mass/volume] in Venous blood

640

5226

1.19

4.28

3.5

4.0

132.45

131.66

g/l

0.41

626

5098

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

137

912

1.45

4.27

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

399

3112

1.24

4.25

1.3

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

321

1.78

4.24

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

121

790

1.48

4.17

1.5

1.4

15711.73

61528.38

e6/l

2.02

545

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

316

1.77

4.15

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

195

1388

1.36

4.15

1.3

—

nmol/l

—

(3051651) Icteric interference index of Serum or Plasma

102

643

1.53

4.15

3.1

3.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

408

3200

1.24

4.14

1.4

1.3

20.65

22.38

u/l

0.55

329

2665

(3018405) Lactate [Moles/volume] in Arterial blood

362

2802

1.25

4.14

4.4

3.9

1.37

1.38

mmol/l

0.02

353

2755

(3051611) Lipemic interference index of Serum or Plasma

146

990

1.43

4.14

2.8

3.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

598

1.55

4.12

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

367

1.71

4.12

1.0

1.3

101.73

102.60

0.08

344

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

324

1.76

4.12

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

207

1.96

4.09

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

207

1.96

4.09

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

207

1.96

4.09

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

207

1.96

4.09

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

383

1.69

4.06

3.0

3.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

150

1026

1.42

4.06

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

347

1.73

4.06

1.0

1.1

78.55

85.65

0.53

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

420

1.66

4.05

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

133

891

1.44

4.03

1.2

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.19

3.97

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

244

1.86

3.94

1.3

1.2

532.08

381.02

pmol/l

0.43

187

(3049717) Cytology report of Urine Cyto stain

306

2337

1.27

3.94

2.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

431

1.64

3.93

1.4

2.07

3.25

0.89

107

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

513

4141

1.20

3.93

2.1

1.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

905

7658

1.15

3.88

1.3

211.43

232.66

miu/ml

1.09

455

3767

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

381

1.67

3.88

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

811

8976

0.87

3.88

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

816

9026

0.87

3.87

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

816

9022

0.87

3.85

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

325

1.73

3.80

3.0

1.9

—

(3019060) Gas panel - Arterial blood

619

5098

1.18

3.79

4.4

4.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

347

1.70

3.79

1.0

1.1

76.90

73.38

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

703

5850

1.17

3.79

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

311

1.74

3.79

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

459

1.60

3.76

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

816

9002

0.87

3.74

1.4

—

(3045424) Erythrocytes [Presence] in Urine

259

1954

1.28

3.71

1.4

—

(4035726) Immunohistochemistry procedure

1006

8605

1.14

3.70

1.5

1.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.14

3.67

1.0

0.12

0.05

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

162

1145

1.37

3.66

4.8

9.9

6.84

7.17

mmol/l

0.49

136

915

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

465

3748

1.20

3.65

2.0

1.8

—

(3024263) Appearance of Synovial fluid

463

1.59

3.64

1.2

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

441

1.60

3.62

2.7

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

426

1.61

3.62

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

102

665

1.48

3.60

1.1

3.98

6.80

nmol/l

0.29

134

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1007

8633

1.13

3.58

2.3

2.1

11.47

11.39

nmol/l

0.10

909

7884

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

551

4519

1.18

3.57

2.5

3.2

95.65

93.86

1.13

519

4347

(3017354) Segmented neutrophils/100 leukocytes in Blood

127

865

1.42

3.57

2.8

2.9

56.50

55.45

0.24

108

736

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

245

1847

1.28

3.55

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3213

29196

1.08

3.48

1.8

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

577

1.51

3.46

2.0

1.8

130.68

145.14

1.21

541

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

884

9640

0.88

3.43

1.5

—

(3022621) pH of Urine by Test strip

886

7558

1.14

3.42

2.9

2.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

376

2998

1.22

3.34

1.5

1.6

441.75

2081.51

e6/l

0.73

310

2411

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

645

1.47

3.33

1.5

1.6

3.87

7.30

nmol/l

0.39

536

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

592

1.49

3.28

1.5

6.28

6.78

u/l

0.14

479

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

149

1060

1.36

3.28

2.4

3.0

5.28

9.31

nmol/l

0.34

143

1027

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

375

2998

1.21

3.25

1.4

1.5

15.10

26.21

e6/l

0.96

294

2292

(3029634) Reagin Ab [Titer] in Serum by VDRL

314

2468

1.23

3.22

2.1

1.9

2.62

6.75

titre

0.97

(3019230) Fractional oxyhemoglobin in Venous blood

232

1762

1.27

3.21

3.1

5.0

65.52

65.10

0.11

232

1754

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

471

1.54

3.20

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

651

1.46

3.19

2.4

2.6

42.43

42.81

0.08

355

(3020911) Cortisol [Moles/time] in 24 hour Urine

510

1.52

3.19

1.3

1.4

75.77

153.27

nmol/24h

1.22

510

(3042111) Morphology [Interpretation] in Bone marrow Narrative

161

1165

1.34

3.18

1.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

563

4676

1.17

3.17

9.0

10.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

971

8376

1.13

3.16

1.9

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3416

31213

1.07

3.15

1.6

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

621

5200

1.16

3.15

2.9

2.4

0.18

0.27

e6/l

2.07

600

5015

(3007919) Fasciola sp Ab [Titer] in Serum

4.57

3.13

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

247

1901

1.26

3.08

4.8

5.5

371.72

381.87

umol/l

0.53

220

1683

(3037692) Legionella sp identified in Specimen by Organism specific culture

280

1.69

3.07

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

243

1870

1.26

3.04

2.1

2.0

4.99

5.44

mmol/24h

1.30

215

1698

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

281

1.69

3.03

1.4

1.3

186.60

113.85

nmol/l

1.09

211

(42870560) Thyrotropin [Units/volume] in Cord blood

296

1.67

3.02

1.0

9.51

8.73

mu/l

0.32

241

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

461

3785

1.18

3.01

1.6

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.76

2.98

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

305

2413

1.22

2.97

3.7

5.0

0.34

0.35

u/ml

0.09

154

1351

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

261

1.70

2.96

6.4

6.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

800

6851

1.13

2.95

1.9

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

299

2365

1.22

2.93

1.4

1.2

4.01

3.98

u/ml

0.02

136

1061

(3001729) Color of Synovial fluid

2.53

2.91

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

173

1283

1.30

2.91

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

171

1.86

2.87

5.4

4.8

40.60

37.36

ug/min

0.10

118

(3008152) Bicarbonate [Moles/volume] in Arterial blood

602

5068

1.15

2.87

6.8

6.6

24.52

24.34

mmol/l

0.59

576

4797

(3006653) Thiamine [Moles/volume] in Blood

603

1.44

2.85

1.4

135.25

136.01

nmol/l

0.07

603

(3008536) Aspergillus sp Ab [Presence] in Serum

186

1.82

2.82

2.1

2.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

262

2054

1.24

2.81

1.8

1.7

2510.77

1877.10

titre

0.24

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

2.01

2.80

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

325

2605

1.21

2.80

1.9

1.8

192.20

184.90

pmol/l

0.50

303

2482

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

201

1.78

2.79

1.4

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

468

3878

1.17

2.77

3.6

3.5

25.04

25.15

mmol/l

0.33

453

3736

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.54

2.76

2.0

1.7

50.87

46.14

umol/l

0.18

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

180

1356

1.28

2.72

1.2

29.00

32.53

nmol/l

—

(40765096) Chromosome analysis panel by Banding

217

1.74

2.72

1.3

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

107

2.08

2.71

1.2

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

154

1.88

2.70

1.7

1.9

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.78

2.67

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

491

4099

1.16

2.65

1.7

1.6

39.69

41.42

nmol/l

0.76

479

4023

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

112

791

1.37

2.65

2.5

2.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

226

1.71

2.65

3.1

2.7

26.94

32.98

mg/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

297

2376

1.21

2.64

1.1

—

(3045142) Bone marrow Pathology biopsy report

120

859

1.35

2.62

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

177

1.80

2.61

1.8

1.5

0.36

0.46

ug/l

0.50

125

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

229

1.69

2.54

1.1

1.0

72.81

73.06

ug/l

0.01

199

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

1073

1.31

2.53

2.0

1.9

23.02

24.14

mg/l

0.10

290

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

305

2458

1.20

2.52

1.3

1.2

3.38

3.56

u/ml

0.07

102

820

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

684

1.39

2.51

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

328

1.56

2.49

2.8

2.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

556

1.43

2.48

1.7

1.5

3.64

2.51

u/field

0.22

406

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1087

11485

0.91

2.48

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

253

1.64

2.48

1.3

51.93

50.33

0.09

219

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

152

1.84

2.48

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

160

1205

1.28

2.46

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

728

1.37

2.46

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

279

2237

1.21

2.45

3.3

2.5

0.84

0.82

nmol/l

0.26

228

1908

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

494

1.45

2.44

1.1

50.53

393.61

ng/l

0.92

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

400

1.50

2.42

1.2

20.13

13.32

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

125

913

1.32

2.41

1.4

1.47

1.41

nmol/l

0.26

117

818

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

158

1192

1.28

2.41

1.4

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.17

2.40

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6418

60130

1.05

2.39

2.6

2.4

—

(3002256) Pathology report gross observation

1663

14964

1.08

2.35

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.41

2.35

5.9

4.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

703

6069

1.12

2.35

2.7

2.8

147.92

137.10

ng/l

0.28

624

5386

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

148

1.83

2.34

2.9

4.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

163

1.78

2.31

4.4

5.8

2.17

2.51

mg/l

0.68

142

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

142

1.84

2.30

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.22

2.29

10.8

9.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

351

1.51

2.28

2.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

351

1.51

2.28

2.3

2.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.46

2.27

1.4

1.3

0.41

0.39

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

275

1.58

2.26

1.1

—

(3012565) Volume of 24 hour Urine

503

1.42

2.24

2.1

1938.46

2050.31

0.41

464

(3000012) Reticulocyte production index

134

1000

1.30

2.24

1.9

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

634

1.37

2.23

2.1

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.46

2.20

1.2

1.1

1.72

1.37

mg/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

103

743

1.34

2.20

1.7

1.3

—

(40758358) Immune stain study

2.52

2.19

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

398

4427

0.86

2.19

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

117

862

1.31

2.16

2.7

2.5

1.86

1.42

g/24h

0.42

437

(40759632) Porphyrins [Mass/mass] in Stool

5.36

2.15

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

581

1.38

2.15

1.6

1.7

33.76

35.30

mmol/l

0.24

523

(1761868) Lipid panel - Serum or Plasma

5171

51561

0.95

2.14

2.4

2.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

138

1042

1.28

2.13

1.3

1.87

1.86

mmol/l

0.01

131

978

(3020393) Adenovirus Ag [Presence] in Stool

242

1.60

2.11

2.0

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

575

1.38

2.10

1.9

1.23

1.33

nmol/l

0.34

461

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

765

6683

1.11

2.10

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

641

1.36

2.10

1.8

3.32

3.31

mg/l

0.01

607

(3044927) Protein electrophoresis panel - Urine

600

1.37

2.10

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

343

1.49

2.09

2.9

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

360

3000

1.16

2.07

2.6

2.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

168

1305

1.25

2.06

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.90

2.05

1.0

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

337

1.49

2.04

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

361

1.47

2.03

2.3

2.0

—

(3004959) Base excess in Arterial cord blood by calculation

260

1.56

2.03

1.0

-3.16

-1.69

mmol/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

704

1.33

2.02

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

474

1.41

2.01

2.1

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

140

1072

1.26

1.96

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

380

1.45

1.96

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

380

1.45

1.96

1.3

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

575

1.36

1.95

1.3

145.89

157.19

mmol/24h

0.73

575

(3006598) pH of Arterial cord blood

263

1.54

1.94

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.13

1.94

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

189

1.64

1.88

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.32

1.87

2.0

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

416

1.42

1.87

2.6

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

416

1.42

1.87

2.6

1.9

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

138

1.75

1.87

3.3

2.1

196.52

160.52

ug/g

0.53

121

(3028717) Thiamine [Mass/volume] in Blood

117

1.82

1.86

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

329

1.47

1.85

1.0

1.1

—

(21494434) Karyotype in Bone marrow

639

1.33

1.85

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

474

1.39

1.85

2.1

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

393

1.43

1.85

1.4

17.91

17.07

umol/l

0.54

352

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.63

1.84

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.53

1.84

1.1

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

608

1.34

1.81

1.2

88.86

84.71

u/l

0.12

539

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

130

1000

1.26

1.78

1.4

10.89

10.95

umol/l

0.04

124

962

(3006922) Hepatitis E virus Ab [Presence] in Serum

132

1018

1.25

1.77

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

4.02

1.76

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

127

1.75

1.74

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

714

1.30

1.73

1.8

1.9

1.94

2.19

u/field

0.22

350

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

274

2275

1.17

1.72

1.1

116.46

117.02

0.12

240

2084

(3013727) Leukocytes other/100 leukocytes in Blood

303

1.47

1.72

4.3

3.5

48.68

50.62

0.26

294

(40763791) Oxygen content in Venous blood by calculation

2.48

1.71

3.0

7.8

10.78

13.72

ml/dl

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

205

1663

1.19

1.70

2.5

2.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

266

2206

1.17

1.70

1.1

141.54

4741.15

iu/ml

0.63

574

(3017315) Amylase [Enzymatic activity/volume] in Urine

591

1.32

1.68

1.2

1.3

178.68

313.97

u/l

2.26

550

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

173

1384

1.21

1.67

1.2

1.1

33.60

39.37

mg/l

1.81

142

1159

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

337

1.43

1.67

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

592

1.32

1.66

1.2

24.17

18.18

u/l

0.26

513

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

122

941

1.25

1.66

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

166

1.63

1.66

1.1

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

495

1.35

1.61

1.5

1.4

13.51

14.34

pmol/l

0.93

424

(43055514) Macroprolactin [Presence] in Serum or Plasma

663

1.30

1.61

1.6

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

121

937

1.25

1.60

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.15

1.60

1.0

7.17

18.21

iu/ml

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

168

1.61

1.59

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.49

1.58

1.5

1.1

368.29

248.37

nmol/l

—

(3019174) dRVVT (LA screen)

132

1.68

1.55

1.3

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

201

1645

1.18

1.54

1.2

1.1

96.96

94.07

0.73

181

1557

(3018738) Hemoglobin F/Hemoglobin.total in Blood

201

1.54

1.52

1.7

3.5

9.72

6.30

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

509

1.33

1.51

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

209

1.53

1.51

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

501

1.33

1.51

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

166

1340

1.20

1.49

1.1

210.58

226.85

mg/l

0.68

147

1176

(3042733) HLA Ab [Presence] in Serum

444

1.35

1.49

5.2

4.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

420

3635

1.12

1.47

2.0

5.01

12.05

iu/l

0.87

179

1501

(3017509) Phencyclidine [Presence] in Urine

290

1.43

1.46

1.8

1.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

347

1.39

1.46

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

347

1.39

1.46

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

347

1.39

1.46

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

513

1.32

1.45

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

463

1.34

1.45

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.76

1.44

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

106

1.73

1.42

1.1

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

205

1.51

1.41

1.3

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

174

1.55

1.41

1.4

1.7

1.55

1.62

mg/l

0.09

150

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

422

3664

1.11

1.40

1.9

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.82

1.40

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.90

1.40

6.7

6.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

114

1.69

1.40

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

198

1.51

1.39

1.9

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

286

1.42

1.37

1.3

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

150

1211

1.20

1.37

1.5

1.4

1.52

1.39

promille

0.50

113

912

(3035320) C reactive protein [Mass/volume] in Body fluid

117

922

1.23

1.37

2.6

2.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

438

1.32

1.30

1.2

1.1

68.47

56.35

u/ml

0.56

427

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

812

0.77

1.29

1.5

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

372

1.35

1.29

3.1

2.8

28.09

28.53

umol/l

0.09

273

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

1008

1.21

1.29

1.2

1.06

ratio

0.02

354

(3005011) Chlamydia sp Ab [Titer] in Serum

226

1.45

1.28

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

243

1.43

1.25

1.4

92.32

105.95

mu/l

0.11

200

(3033799) Differential panel - Peritoneal fluid

243

1.43

1.25

1.8

2.0

—

(3036180) Methadone [Presence] in Urine

149

1215

1.19

1.25

3.3

2.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.41

1.24

7.8

3.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

442

1.31

1.24

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

987

1.20

1.23

1.4

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

299

2570

1.13

1.23

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

426

3735

1.10

1.22

1.6

1.5

0.37

0.45

nmol/l

1.30

333

3045

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

205

1.46

1.21

1.3

1.2

0.45

128.30

mg/l

2.37

148

(3032352) Blasts [#/volume] in Cerebral spinal fluid

135

1.57

1.19

1.8

3.7

—

(3044009) aPTT.lupus sensitive (LA screen)

135

1.57

1.19

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.32

1.19

1.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.32

1.19

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

238

1.42

1.19

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

143

1.55

1.18

2.0

1.8

—

(3019977) pH of Arterial blood

447

1.30

1.16

2.3

2.9

7.44

7.42

0.58

127

(3051387) C reactive protein [Mass/volume] in Capillary blood

282

2427

1.12

1.15

3.3

3.0

21.38

25.26

mg/l

1.37

168

1483

(4281824) Cell count and differential, peritoneal fluid

106

1232

0.83

1.14

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

238

0.61

1.12

5.7

7.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

407

1.31

1.12

2.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

2.25

1.10

1.1

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

754

1.22

1.09

1.5

1.7

1112363.75

1417270.41

iu/ml

—

(3016018) Differential panel - Cerebral spinal fluid

181

1521

1.15

1.08

1.4

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

187

1.45

1.06

1.3

1.5

12.65

13.01

g/l

0.08

139

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

445

1.28

1.06

2.4

111.09

110.83

ng/l

0.01

308

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

165

1380

1.16

1.06

1.4

1.3

4.93

5.97

umol/l

3.09

157

1278

(3000330) Specific gravity of Urine by Test strip

537

4799

1.08

1.05

3.3

2.7

—

(3013336) Amino acids [Identifier] in Serum or Plasma

109

1.59

1.05

2.6

2.5

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.11

1.05

1.7

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

827

0.80

1.03

6.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

371

1.30

1.02

2.0

2.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

796

1.20

1.02

2.1

1.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.05

1.02

1.3

1.2

—

mmol/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.63

1.01

4.8

4.9

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

214

1.40

1.00

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

112

913

1.19

1.00

1.1

0.97

1.03

u/l

1.33

386

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.99

0.99

1.0

2.6

1.86

2.20

mu/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.85

0.99

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.19

0.99

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

156

1309

1.15

0.98

2.3

1.6

—

(3045716) Anion gap in Serum or Plasma

374

1.29

0.98

2.0

2.4

9.67

10.01

mmol/l

0.22

363

(3015183) Erythrocyte sedimentation rate

109

889

1.18

0.97

1.1

1.2

—

(3027874) Urate [Moles/volume] in Urine

0.00

0.97

0.0

1.1

—

1.75

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

151

1.47

0.96

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

547

1.24

0.96

1.4

1.7

—

(3023410) Appearance of Cerebral spinal fluid

174

1474

1.14

0.96

1.7

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

591

1.23

0.96

7.0

6.2

78.78

5745.44

u/ml

0.59

126

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

427

1.27

0.95

1.3

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.95

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

1981

19809

0.96

0.95

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.59

0.94

5.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

1.33

0.94

2.6

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

1.33

0.94

2.6

2.9

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.15

0.91

1.3

1.1

0.09

0.08

g/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

194

1.39

0.90

2.7

2.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.70

0.90

1.0

1.1

5.58

12.76

u/l

1.01

(3036782) Glucose [Moles/volume] in Pleural fluid

596

1.22

0.90

1.4

1.3

5.66

6.16

mmol/l

1.13

553

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.07

0.89

1.2

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

685

1.20

0.89

1.1

1.2

66.00

75.42

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

253

1.34

0.88

2.8

2.5

1.34

1.47

mmol/l

0.12

185

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

598

1.21

0.87

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

256

0.68

0.87

5.9

7.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.84

0.86

5.6

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

709

6462

1.06

0.84

1.6

4.01

3.63

mg/l

0.53

524

4460

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.93

0.84

1.7

1.2

156.50

117.60

nmol/l

—

(3046861) Legionella sp Ag [Presence] in Urine

1.93

0.84

1.2

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

859

7876

1.06

0.83

1.8

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.59

0.83

1.0

1.3

0.44

0.81

umol/24h

—

(3003577) Lead [Moles/volume] in Blood

110

0.53

0.83

1.0

1.4

—

0.24

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1111

10258

1.05

0.82

1.7

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

215

1.35

0.81

1.4

1.2

39.85

38.57

g/l

0.18

120

(3050129) First trimester maternal screen panel - Serum or Plasma

1144

11529

0.95

0.81

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1727

17253

0.96

0.81

1.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.72

0.81

2.1

0.51

0.57

umol/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

291

1.29

0.81

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

1123

1.14

0.81

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

296

2617

1.09

0.80

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

224

1.34

0.80

1.5

1.4

47.21

38.01

0.66

155

(40761539) Cells [Type] in Urine sediment by Light microscopy

241

1.32

0.80

1.2

—

(3047189) Immunofixation for 24 hour Urine

275

1.30

0.79

2.1

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

150

1.42

0.79

1.2

1.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.79

0.0

1.3

—

2524.78

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

158

0.61

0.79

1.1

1.4

46.60

26.51

—

148

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.81

0.78

1.2

1.67

1.28

u/field

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.81

0.78

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.77

0.0

1.3

—

1.92

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

727

6653

1.06

0.77

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

320

1.27

0.76

1.9

2.4

—

(3001556) Androgen free Index in Serum or Plasma

269

1.29

0.75

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

112

1.47

0.73

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.64

0.73

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

409

1.23

0.73

2.0

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.59

0.72

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

300

2671

1.09

0.72

1.2

1.3

—

(3034614) HLA Ag [Interpretation]

1.78

0.72

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

137

1.41

0.72

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

154

1.38

0.70

1.3

1.4

57.33

58.10

—

(3003434) Protein [Mass/volume] in Pleural fluid

748

1.16

0.70

1.5

1.4

34.56

35.00

g/l

0.12

678

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

178

1548

1.11

0.70

1.6

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

508

1.20

0.70

4.4

5.5

79.73

2745.27

mg/l

2.07

379

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

425

4379

0.94

0.69

1.4

1.3

4.79

3.64

ug/l

1.14

385

4063

(40763590) HLA-DQ beta [Type]

1.69

0.69

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.69

0.69

1.0

—

(3011648) Oxygen content in Venous blood

106

894

1.15

0.69

3.7

5.9

11.68

11.31

0.44

106

894

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

747

7566

0.95

0.69

2.6

2.8

28.39

39.26

u/ml

3.08

721

7299

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

804

1.15

0.68

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

918

8487

1.05

0.68

1.5

1.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.86

0.68

1.2

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.86

0.68

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.52

0.68

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

225

1985

1.10

0.68

2.8

2.4

104.95

101.95

ug/min

0.04

144

1287

(3013862) HLA-DP [Type]

1.65

0.67

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

117

0.58

0.67

5.3

5.9

—

(3012441) Differential panel - Pleural fluid

582

1.18

0.67

1.5

—

(3014891) Appearance of Pleural fluid

1.59

0.66

1.9

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1549

15432

0.97

0.66

3.3

3.4

21.52

21.65

0.11

560

5990

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.79

0.66

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

190

1.32

0.65

1.3

1.2

—

89.27

—

(3043410) Blood group antigens tested for on Red Blood Cells

338

0.77

0.65

1.2

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

466

0.81

0.64

3.2

3.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

174

1.33

0.64

1.7

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

465

0.81

0.63

6.4

6.2

—

(40768795) Lymph node Pathology biopsy report

118

1010

1.13

0.63

1.3

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

133

1147

1.12

0.63

11.1

12.2

0.56

0.61

mmol/l

2.09

124

1057

(3050794) Legionella sp Ab [Presence] in Serum

100

1.45

0.63

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.47

0.63

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

632

1.16

0.61

1.5

1.4

46809.46

59617.24

e6/l

0.25

364

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

197

1739

1.09

0.61

1.5

8.19

7.32

mmol/l

2.23

192

1708

(3003694) ABO and Rh group [Type] in Blood

4614

45227

0.98

0.61

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

660

1.16

0.60

1.3

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.6

—

(3000285) Sodium [Moles/volume] in Blood

101

1.43

0.60

1.5

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.48

0.60

1.2

1.5

14.72

21.42

pmol/l

0.80

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

285

2558

1.08

0.60

1.7

1.6

7.49

7.54

mmol/l

0.17

278

2449

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

146

0.66

0.59

6.8

7.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.54

0.59

2.1

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

341

1.22

0.59

1.5

1.7

—

740.33

—

(40768793) Breast Pathology biopsy report

277

2872

0.93

0.58

1.3

—

(3016750) Collection duration of Urine

493

1.18

0.57

2.9

2.3

503.54

506.27

min

0.08

397

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.70

0.57

2.3

2.4

—

(3049233) Organic acids panel - Urine

1.52

0.57

1.5

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

441

1.18

0.56

2.4

2.0

15.36

15.63

umol/l

0.06

441

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

239

1.25

0.55

1.5

2.0

3.11

2.16

ug/l

0.59

146

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

539

0.84

0.54

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.57

0.54

1.5

4.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.47

0.53

3.8

3.2

—

(3035880) pH of Pleural fluid

316

0.79

0.53

1.6

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

866

0.88

0.52

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

154

1358

1.10

0.52

1.8

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

732

0.87

0.51

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

181

1.28

0.51

2.0

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

780

1.13

0.51

2.8

2.9

0.91

0.82

nmol/l

0.97

575

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

238

2139

1.08

0.51

2.7

2.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

771

1.13

0.51

1.2

7.43

12.85

u/ml

0.39

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.49

0.51

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

369

3367

1.06

0.51

3.7

4.7

1.82

1.75

0.35

343

3127

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

690

1.13

0.50

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.38

0.50

2.0

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

106

1.37

0.49

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

157

1.29

0.48

1.7

1.6

—

(3008607) Semen analysis panel

138

0.70

0.47

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

150

1.29

0.45

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

217

1956

1.07

0.45

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.41

0.45

2.1

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

706

1.12

0.45

1.6

1.4

2565.10

2436.59

e6/l

0.08

505

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

506

1.15

0.45

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

266

0.80

0.44

1.5

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

169

1761

0.93

0.44

1.5

1.4

31.43

31.27

nmol/l

0.02

154

1635

(3007930) Methemoglobin/Hemoglobin.total in Blood

362

3319

1.05

0.44

3.7

4.8

0.90

0.92

0.29

336

3092

(4034850) Laboratory test

391

3593

1.05

0.44

8.8

7.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

874

0.89

0.44

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

256

1.21

0.44

1.1

—

(3024471) HLA-A [Type]

445

1.15

0.42

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

445

1.15

0.42

1.1

1.0

247.91

309.30

ng/l

1.96

327

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.36

0.41

1.1

1.0

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

32.80

—

(3024932) HLA-DR beta [Type]

439

1.14

0.40

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

171

1.24

0.39

1.8

2.2

8.85

7.28

mmol/l

0.57

(3042517) Benzodiazepines panel - Urine

305

1.17

0.38

4.8

2.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

316

2903

1.05

0.38

3.4

3.6

493.13

1574.37

u/ml

0.60

285

2498

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

743

1.10

0.38

1.1

94.93

92.82

0.25

599

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

450

1.14

0.38

1.1

1.0

30.95

42.13

ng/l

2.69

321

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.38

0.38

1.0

1.3

—

(3006462) Nitrate [Presence] in Urine

597

1.12

0.37

3.3

2.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

138

1.26

0.36

1.1

1.2

7.76

343.43

ug/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.36

0.36

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

191

1.21

0.36

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

112

996

1.09

0.36

1.9

1.6

6.15

6.02

mmol/l

0.19

765

(40760410) HLA-B [Type] by High resolution

1.45

0.36

1.0

—

(40760409) HLA-A [Type] by High resolution

1.45

0.36

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

840

0.91

0.35

2.5

2.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

104

1.30

0.35

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

117

1045

1.08

0.34

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

274

2518

1.05

0.34

1.5

1.4

6.71

6.69

mmol/l

0.05

255

2296

(3006270) Folate [Moles/volume] in Blood

841

1.09

0.34

1.2

1.1

390.22

412.48

nmol/l

0.49

783

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

345

1.15

0.34

1.2

1.1

—

(3004451) EKG impression Narrative

336

1.15

0.34

1.6

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.35

0.34

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.35

0.34

3.2

5.6

0.40

0.19

mmol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

202

1.20

0.33

1.5

1.4

50.85

58.46

0.48

174

(3023487) Leukocytes [#/volume] in Peritoneal fluid

283

1.16

0.33

1.7

2.1

597.52

944.38

e6/l

0.72

187

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.67

0.33

3.7

7.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

165

1693

0.94

0.32

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

614

1.10

0.31

1.7

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

449

1.12

0.31

1.1

1.0

880.73

746.17

ng/l

1.36

320

(3009015) Lactate [Moles/volume] in Synovial fluid

1.34

0.31

1.2

4.46

4.92

mmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

258

1.16

0.30

1.7

1.9

13720.40

7990.47

e6/l

0.24

129

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.30

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.26

0.30

1.1

—

(3045788) Cell count panel - Pleural fluid

562

1.10

0.29

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

627

1.09

0.29

2.8

2.3

683.75

627.16

0.55

469

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

224

1.16

0.28

2.0

1.3

—

(3007463) Buprenorphine [Presence] in Urine

108

1.25

0.28

3.5

8.2

—

(3047181) Lactate [Moles/volume] in Blood

325

3019

1.04

0.28

4.2

5.0

1.28

1.26

mmol/l

0.17

286

2652

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

555

1.10

0.27

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

180

1.18

0.27

1.2

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

118

1.23

0.26

1.1

1.6

—

9.33

—

(3000034) Microalbumin [Mass/volume] in Urine

863

0.93

0.26

3.0

2.8

33.84

61.84

mg/l

1.19

625

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

101

1.24

0.25

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

110

1.23

0.25

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

146

1.19

0.24

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

164

1.18

0.24

1.1

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

144

1319

1.05

0.24

1.4

1.2

46.18

32.33

u/l

0.26

129

1158

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

358

3567

0.97

0.23

1.4

69.64

104.80

pmol/l

2.69

348

3474

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

201

1.15

0.23

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1017

0.94

0.23

1.3

193.28

184.22

pmol/l

0.16

1017

(4146454) Self-monitoring of blood glucose

768

0.93

0.23

2.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

183

0.84

0.22

9.1

7.3

—

(3044007) Cell count panel - Peritoneal fluid

229

1.14

0.22

1.7

1.9

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.27

0.22

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

220

1.14

0.22

1.1

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

654

6178

1.02

0.22

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2034

19410

1.01

0.22

3.8

3.9

2.15

2.18

ug/l

0.04

1833

17706

(3034092) Cytoplasmic Ig cells/100 cells in Blood

175

1.16

0.22

1.8

4.9

—

(3048879) Bone marrow aspiration report

166

1.16

0.22

1.4

2.3

—

(40758292) HTLV I+II Ab panel - Serum

230

1.13

0.21

1.3

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

7.4

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

31.78

—

(3032868) Hemoglobin electrophoresis panel in Blood

192

0.85

0.21

1.4

1.6

—

(3034426) Prothrombin time (PT)

536

1.08

0.21

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.79

0.21

2.4

3.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

194

1.14

0.21

1.2

1.3

28.41

49.20

ng/l

0.73

114

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.20

1.3

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.20

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

141

1424

0.96

0.20

4.1

4.6

99.96

118.55

u/ml

0.17

503

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

125

1151

1.05

0.19

1.1

—

(3020650) Glucose [Presence] in Urine

391

1.09

0.18

1.2

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

644

1.06

0.18

2.6

51.11

51.82

umol/l

0.06

587

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

410

1.08

0.18

1.9

2.0

71.43

158.88

ug/min

0.57

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

124

1.17

0.17

5.6

9.2

4.64

5.58

mmol/l

1.29

124

(4212803) Bone marrow aspirate examination

1.13

0.17

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.22

0.17

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.22

0.17

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

212

1981

1.03

0.17

3.9

3.3

—

(40768441) Liver Pathology biopsy report

891

1.05

0.17

1.3

1.4

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.17

0.16

4.0

2.2

32.50

36.24

umol/l

—

(3025130) Human papilloma virus identified in Specimen

307

2890

1.03

0.16

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

863

0.95

0.16

2.4

2.1

105.95

105.67

mmol/l

0.22

853

(3041354) Potassium [Moles/volume] in Venous blood

863

0.95

0.16

2.4

2.1

3.97

3.99

mmol/l

0.19

853

(3020356) Listeria sp identified in Specimen by Organism specific culture

162

1.13

0.15

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.76

0.15

1.0

5.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.14

0.15

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

247

2446

0.97

0.14

1.4

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

129

1201

1.04

0.14

18.7

19.2

1372.32

2191.45

nmol/l

0.52

124

1165

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

136

1.14

0.14

2.1

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

267

1.08

0.13

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.17

0.12

2.5

2.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

165

1.11

0.12

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

727

0.96

0.12

1.2

—

(3017704) Immunofixation for Urine

342

0.93

0.12

1.6

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

110

1.14

0.11

1.5

1.9

0.77

0.62

u/field

0.30

110

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

103

962

1.03

0.10

1.4

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

195

1.09

0.10

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.12

0.10

1.0

1.1

22.56

17.88

g/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.05

0.09

1.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

234

1.07

0.09

1.5

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.85

0.07

7.3

6.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.83

0.07

1.8

2.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.09

0.07

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.03

0.07

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1164

11304

0.99

0.07

2.5

0.64

0.70

ug/l

1.91

666

6279

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.87

0.07

1.4

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.88

0.06

1.0

1.1

1.82

1.78

umol/24h

—

(3008037) Lactate [Moles/volume] in Venous blood

166

1629

0.98

0.06

2.8

2.7

1.41

1.51

mmol/l

0.76

160

1586

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

686

1.03

0.06

1.6

—

(3022689) Creatine [Moles/volume] in Urine

294

0.95

0.06

1.8

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

936

1.02

0.05

1.4

1.3

—

(3039000) Anion gap in Blood

206

1963

1.01

0.05

4.9

6.2

11.34

11.25

mmol/l

0.16

188

1750

(3018572) Chloride [Moles/volume] in Blood

206

1964

1.01

0.05

4.9

6.2

104.90

105.58

mmol/l

1.49

188

1751

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

379

0.97

0.04

3.3

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

260

1.04

0.03

4.5

9.4

—

(3022670) pH of Venous cord blood

105

0.92

0.03

1.1

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

548

1.02

0.03

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

357

0.97

0.02

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

958

0.99

0.02

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1862

18004

1.00

0.02

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

841

8103

1.00

0.01

3.4

4.0

49.21

23.03

ug/l

0.52

653

6113

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

162

1554

1.01

0.01

3.2

3.7

315.81

468.25

u/ml

0.26

149

1416

(3034988) Calcium [Moles/volume] in Capillary blood

235

1.03

0.01

2.2

5.0

1.19

1.20

mmol/l

0.28

219

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

197

1.03

0.00

2.6

2.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

226

1.03

0.00

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

172

1.01

0.00

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

108

0.98

0.00

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

109

0.97

0.00

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

215

0.99

0.00

2.4

4.5

1.20

1.21

mmol/l

0.19

197

(3008116) Ketones [Moles/volume] in Urine by Test strip

227

0.98

0.00

1.7

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

881

1.00

0.00

3.5

3.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

206

0.98

0.00

1.1

1.50

1.00

umol/24h

—

101

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.4

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.93

-0.00

1.4

1.6

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

17.3

—

5.77

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.95

-0.00

2.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.93

-0.00

1.2

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.90

-0.00

1.1

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.85

-0.00

1.0

1.3

261.18

555.61

nmol/l

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.99

-0.00

1.0

38.34

30.59

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.95

-0.00

1.3

1.4

280.00

298.84

umol/24h

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ATOPIC_STRICT_REIMB – Atopic dermatitis, strict definition with reimbursement

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Atopic dermatitis, strict definition with reimbursement

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Atopic dermatitis, strict definition with reimbursement (ATOPIC_STRICT_REIMB)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints